Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 742 articles:
HTML format

Single Articles

    December 2023
  1. POWIS KM, Moschen G, Jexler J, Ronan A, et al
    Who is championing programming to ensure children who are HIV-exposed yet uninfected thrive to their fullest potential?
    AIDS. 2023;37:2433-2434.

  2. LASMANOVICH R, Atias D, Mor O, Obolski U, et al
    False-positive HIV screening tests during the COVID-19 pandemic, a passing trend?
    AIDS. 2023;37:2430-2432.
    PubMed     Abstract available

  3. CLEMENTE T, Lolatto R, Papaioannu Borjesson R, Fabbiani M, et al
    Sexually transmitted infections in people with multidrug-resistant HIV.
    AIDS. 2023;37:2425-2430.
    PubMed     Abstract available

  4. SMITH-SREEN J, Bosire R, Farquhar C, Katz DA, et al
    Leveraging emergency care to reach key populations for 'the last mile' in HIV programming: a waiting opportunity.
    AIDS. 2023;37:2421-2424.

    Predicting acute kidney injury: do we need biomarkers?
    AIDS. 2023;37:2419-2420.

  6. O'SHEA JG, Cholli P, Heil EL, Buchacz K, et al
    Considerations for long-acting antiretroviral therapy in older persons with HIV.
    AIDS. 2023;37:2271-2286.
    PubMed     Abstract available

    November 2023
  7. HOLDEN CJ, Lampe FC, Burns FM, Chaloner C, et al
    Association of age at ART initiation with CD4:CD8 ratio recovery among virally suppressed people living with HIV, 2001-2019.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003801.
    PubMed     Abstract available

  8. JOHNSON LF, Myer L, Jamieson L, Meyer-Rath G, et al
    The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants: a modelling study.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003803.
    PubMed     Abstract available

  9. MA H, Liang W, Han A, Zhang Q, et al
    Ambient particulate matter and renal function decline in HIV/AIDS patients: exploring the mediating role of TyG index.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003802.
    PubMed     Abstract available

  10. TINCATI C, Bono V, Cannizzo ES, Tosi D, et al
    Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003799.
    PubMed     Abstract available

  11. CHERKOS AS, Cranmer LM, Njuguna I, LaCourse SM, et al
    Effect of TB-HIV co-treatment on clinical and growth outcomes among hospitalized children newly initiating antiretroviral therapy.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003797.
    PubMed     Abstract available

  12. JUSTMAN J, Wright C, El-Sadr WM
    Ending the HIV Epidemic in the US: lessons from Eswatini.
    AIDS. 2023 Nov 28. doi: 10.1097/QAD.0000000000003726.

  13. GREGSON CL, Rehman AM, Rukuni R, Mukwasi-Kahari C, et al
    Perinatal HIV infection is associated with deficits in muscle function in children and adolescents: a cross-sectional study in Zimbabwe.
    AIDS. 2023 Nov 22. doi: 10.1097/QAD.0000000000003795.
    PubMed     Abstract available

  14. WILLIAMS PL, Karalius B, Patel K, Aschengrau A, et al
    Fetal growth assessed via ultrasound in relation to maternal HIV infection status and antiretroviral regimens.
    AIDS. 2023 Nov 22. doi: 10.1097/QAD.0000000000003796.
    PubMed     Abstract available

  15. HAIDAR L, Crane HM, Nance RM, Webel A, et al
    Weight loss associated with semaglutide treatment among people with HIV.
    AIDS. 2023 Nov 17. doi: 10.1097/QAD.0000000000003791.
    PubMed     Abstract available

  16. CHAWKI S, Goldwirt L, Mouhebb ME, Gabassi A, et al
    Ex vivo rectal tissue infection with HIV-1 to assess time to protection following oral PrEP with TDF/FTC (a sub-study of the ANRS PREVENIR study).
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003789.
    PubMed     Abstract available

  17. DAWIT R, Goedel WC, Reid SC, Doshi JA, et al
    Geographic variations of PrEP reversal and abandonment among US counties.
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003790.
    PubMed     Abstract available

  18. KNUDSEN AD, Eskelund CW, Benfield T, Zhao Y, et al
    Clonal hematopoiesis of indeterminate potential in Persons living with HIV.
    AIDS. 2023 Nov 16. doi: 10.1097/QAD.0000000000003788.
    PubMed     Abstract available

  19. OOMEN PGA, van Welzen BJ, Bronsveld I, Hoepelman AIM, et al
    Response to correspondence to 'No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV'.
    AIDS. 2023;37:2268-2269.

  20. BYANOVA KL, Huang L
    Response to: 'No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV'.
    AIDS. 2023;37:2267-2268.

  21. ROSEN JG, Cepeda J, Park JN
    Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States.
    AIDS. 2023;37:2262-2265.
    PubMed     Abstract available

  22. GONZALEZ-SERNA A, Macias J, Rincon P, Arriaza MJ, et al
    Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain.
    AIDS. 2023;37:2259-2262.
    PubMed     Abstract available

  23. KOUAMOU V, Makadzange AT
    Simplified regimens for AIDS-related cryptococcal meningitis - improving its access in Africa.
    AIDS. 2023;37:2253-2257.

  24. MASENGA SK, Woolley IJ
    Addressing atherosclerotic cardiovascular disease risk in persons with HIV.
    AIDS. 2023;37:2251-2252.

  25. FALUTZ J, Lee D
    Frailty and cognition in older people with HIV: recognizing the importance of geriatric syndromes.
    AIDS. 2023;37:2247-2249.

  26. WOOD BR
    Metabolic dysfunction associated steatotic liver disease in persons with HIV: understanding the serious implications and renaming of 'fatty liver disease'.
    AIDS. 2023;37:2245-2246.

  27. AGNIHOTRI SP, Overton ET
    Is it possible to get a two-for-one? Can we slow cognitive decline by treating vascular disease risk factors?
    AIDS. 2023;37:2243-2244.

  28. PASTERNAK AO, Tsukamoto T, Berkhout B
    'Zombie' proviruses in the spotlight: exploring the dark side of HIV persistence.
    AIDS. 2023;37:2239-2241.

  29. XIA Q, Farovitch L, Bertolino D, Romano A, et al
    Improvement in CD4+ cell count among people with HIV in New York City, 2007-2021.
    AIDS. 2023;37:2191-2198.
    PubMed     Abstract available

  30. LANTZ AM, Cottrell ML, Corbett AH, Chinula L, et al
    Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi.
    AIDS. 2023;37:2185-2190.
    PubMed     Abstract available

  31. O'SHEA JG, Bonacci RA, Cholli P, Kimball A, et al
    HIV and mpox: a rapid review.
    AIDS. 2023;37:2105-2114.
    PubMed     Abstract available

  32. FILIP I
    Use of statins in individuals with HIV and low cardiovascular risk: the next stop along the route to optimized risk management.
    AIDS. 2023;37:N19-N20.

  33. FILIP I
    The steep cost of HIV treatment interruptions.
    AIDS. 2023;37:N17.

  34. SILVERBERG MJ, Pimentel N, Leyden WA, Leong TK, et al
    Initial antiretroviral therapy regimen and risk of heart failure.
    AIDS. 2023 Nov 14. doi: 10.1097/QAD.0000000000003786.
    PubMed     Abstract available

  35. CHERKOS AS, LaCourse SM, Kinuthia J, Mecha J, et al
    Maternal breastfeeding and education impact infant growth and development more than in utero HIV/ART exposure in context of universal ART: a prospective study.
    AIDS. 2023 Nov 14. doi: 10.1097/QAD.0000000000003785.
    PubMed     Abstract available

  36. TRUNFIO M, Sacchi A, Vai D, Pittaluga F, et al
    Intrathecal production of anti-EBV Viral Capsid Antigen IgG is associated with Neurocognition and tau pathology in people with HIV.
    AIDS. 2023 Nov 8. doi: 10.1097/QAD.0000000000003775.
    PubMed     Abstract available

  37. ZHANG H, Hindman JT, Lin L, Davis M, et al
    A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV.
    AIDS. 2023 Nov 8. doi: 10.1097/QAD.0000000000003783.
    PubMed     Abstract available

  38. WAHOME E, Otieno FO, Kimani J, Boyd A, et al
    Impact of COVID-19-related clinic closures on HIV incidence in a multicentre study of young adult MSM and transgender women in Kenya.
    AIDS. 2023 Nov 8. doi: 10.1097/QAD.0000000000003782.
    PubMed     Abstract available

  39. WIRTH M, Ruckes C, Michel M, Schattenberg JM, et al
    Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection.
    AIDS. 2023 Nov 6. doi: 10.1097/QAD.0000000000003779.
    PubMed     Abstract available

  40. KOOFHETHILE CK, Gao C, Chang C, Lian X, et al
    The HIV-2 proviral landscape is dominated by defective proviruses.
    AIDS. 2023 Nov 2. doi: 10.1097/QAD.0000000000003776.
    PubMed     Abstract available

  41. CHAN P, Moreland S, Sacdalan C, Kroon E, et al
    Cerebrospinal fluid pleocytosis is associated with HIV-1 neuroinvasion during acute infection.
    AIDS. 2023 Nov 2. doi: 10.1097/QAD.0000000000003777.
    PubMed     Abstract available

  42. AHONKHAI AA, Bian A, Robbins NN, Maurer LA, et al
    Characterizing residential mobility among people living with HIV in tennessee and its impact on HIV care outcomes.
    AIDS. 2023 Nov 2. doi: 10.1097/QAD.0000000000003778.
    PubMed     Abstract available

  43. PETERSON M, Briceno-Robaugh R, O'Connor S, Date A, et al
    Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief.
    AIDS. 2023;37:2103-2104.

  44. BARROS AWP, Sales PHDH, Feitosa LSG, Carvalho AAT, et al
    Is HIV positive a risk factor or contraindication in dental implant therapy?
    AIDS. 2023;37:2100-2101.
    PubMed     Abstract available

  45. FRANCOIS K, Van Onacker JD, Jordan MR, Journel I, et al
    First case report of a perinatally HIV-infected infant with HIV resistance to dolutegravir associated with tenofovir/lamivudine/dolutegravir use in mothers.
    AIDS. 2023;37:2097-2099.
    PubMed     Abstract available

  46. BREW BJ, Clifford DB
    Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?
    AIDS. 2023;37:2095-2096.

  47. BOLZENIUS JD, Goodkin K
    Variability in the relationships between auditory processing and neurocognitive status among older adults with HIV.
    AIDS. 2023;37:2091-2093.

  48. KAUR G, Perry RT
    Preventing measles in children and adolescents with HIV.
    AIDS. 2023;37:2087-2089.

  49. FILIP I
    Cognitive impairment in people with HIV: one step closer to criteria that capture neurocognitive diversity.
    AIDS. 2023;37:N15-N16.

  50. FILIP I
    Stepping outside the comfort zone may be key to improving HIV prevention in vulnerable communities.
    AIDS. 2023;37:N13-N14.

    October 2023
  51. CHINBUNCHORN T, Mayer KH, Campbell J, Alm DK, et al
    HIV pre-exposure prophylaxis provision by U.S. Health centers in 2021.
    AIDS. 2023 Oct 31. doi: 10.1097/QAD.0000000000003774.
    PubMed     Abstract available

  52. JARRIN I, Rava M, Raposo JDR, Rivero A, et al
    Life expectancy of people with HIV on antiretroviral therapy in Spain.
    AIDS. 2023 Oct 30. doi: 10.1097/QAD.0000000000003772.
    PubMed     Abstract available

  53. MASTRANGELO A, Scotti GM, Manteiga JG, Gisslen M, et al
    Alterations in glutamate, arginine, and energy metabolism characterize CSF and plasma metabolome of persons with HIV-associated dementia.
    AIDS. 2023 Oct 30. doi: 10.1097/QAD.0000000000003773.
    PubMed     Abstract available

  54. EALER C, Niemczak CE, Nicol T, Magohe A, et al
    Auditory neural processing in children living with HIV uncovers underlying central nervous system dysfunction.
    AIDS. 2023 Oct 30. doi: 10.1097/QAD.0000000000003771.
    PubMed     Abstract available

  55. CUMMINS B, Johnson K, Schneider JA, Del Vecchio N, et al
    Leveraging social networks for identification of people living with HIV who are virally unsuppressed.
    AIDS. 2023 Oct 27. doi: 10.1097/QAD.0000000000003767.
    PubMed     Abstract available

  56. HORNER MJ, Shiels MS, McNeel TS, Monterosso A, et al
    Real-world use of antiretroviral therapy and risk of cancer among people living with HIV in Texas.
    AIDS. 2023 Oct 27. doi: 10.1097/QAD.0000000000003770.
    PubMed     Abstract available

  57. FILIP I
    Post-treatment control after vertical HIV transmission: decoding innate immune differences may hold the key to potential cure.
    AIDS. 2023 Oct 27. doi: 10.1097/QAD.0000000000003769.

  58. CORNELISSE VJ, Murphy D, Lee SJ, Stoove M, et al
    Physical and mental health of long-term users of HIV pre-exposure prophylaxis (PrEP) in Australia: The X-PLORE Cohort.
    AIDS. 2023 Oct 23. doi: 10.1097/QAD.0000000000003768.
    PubMed     Abstract available

  59. ZINCK MJ, Minichiello SN, Fick CA, Sawry S, et al
    Virtual case management: a differentiated approach to HIV prevention, treatment, and care.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003762.

  60. LAI M, Madden E, Shlipak MG, Scherzer R, et al
    Association of urine biomarkers of kidney health with subclinical cardiovascular disease in a MACS substudy.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003761.
    PubMed     Abstract available

  61. KOSS CA, Ayieko J, Kabami J, Balzer LB, et al
    Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda: a randomized trial.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003763.
    PubMed     Abstract available

  62. LARTEY M, Ganu VJ, Tachi K, Yang H, et al
    Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and HBV viral suppression.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764.
    PubMed     Abstract available

  63. WANG Y, Wu G, Wen Z, Lei H, et al
    HAART-related effects on morphological connectivity in HIV: an individual-level morphological brain network study.
    AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003759.
    PubMed     Abstract available

  64. ZHANG J, Sun Y, Chen X, Ye Y, et al
    Incidence, clearance, and factors associated with anal HPV infection among men with HIV: a cohort study in China.
    AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003755.
    PubMed     Abstract available

  65. BHATTACHARYA D, Guo R, Tseng CH, Emel L, et al
    Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-saharan Africa, HPTN 046- a post-hoc analysis.
    AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003752.
    PubMed     Abstract available

  66. NDUKWE SO, Patel H, Shelton B, Concha-Garcia S, et al
    People with HIV at the end of life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research.
    AIDS. 2023 Oct 18. doi: 10.1097/QAD.0000000000003754.
    PubMed     Abstract available

  67. MPEBE GGA, Phinius BB, Mutenga S, Baruti K, et al
    Hepatitis B surface antigen loss in chronic hepatitis B virus and HIV-1 Co-Infections individuals in Botswana.
    AIDS. 2023 Oct 16. doi: 10.1097/QAD.0000000000003753.
    PubMed     Abstract available

  68. CHAMMARTIN F, Griessbach A, Kusejko K, Audige A, et al
    Bridging the Gap: identifying factors impacting mRNA SARS-CoV-2 vaccine booster response in people living with HIV-1.
    AIDS. 2023 Oct 12. doi: 10.1097/QAD.0000000000003751.
    PubMed     Abstract available

  69. VAN GEUNS D, Arts RJ, de Vries G, Wit FW, et al
    Screening for tuberculosis infection and effectiveness of preventive treatment among people living with HIV in low-incidence settings: a systematic review and meta-analysis.
    AIDS. 2023 Oct 12. doi: 10.1097/QAD.0000000000003747.
    PubMed     Abstract available

  70. CLAY CE, Hoover KW, Le Guen Y, Bennett CL, et al
    Estimates of HIV testing at Visits to U.S. emergency departments, 2014-2020.
    AIDS. 2023 Oct 11. doi: 10.1097/QAD.0000000000003750.
    PubMed     Abstract available

  71. PARKER VL, Baker ZL, Stone BJ, Singh K, et al
    High HIV prevalence in gestational trophoblastic neoplasia patients: experience from an expert UK treatment centre.
    AIDS. 2023 Oct 10. doi: 10.1097/QAD.0000000000003738.
    PubMed     Abstract available

  72. SILVA MS, Coutinho C, Torres TS, Peixoto EM, et al
    Mpox severity and associated hospitalizations among people living with HIV and related immunosuppression in Brazil.
    AIDS. 2023 Oct 7. doi: 10.1097/QAD.0000000000003748.
    PubMed     Abstract available

  73. CABRAL-PICCIN MP, Briceno O, Papagno L, Liouville B, et al
    CD8+ T cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapy.
    AIDS. 2023 Oct 6. doi: 10.1097/QAD.0000000000003746.
    PubMed     Abstract available

  74. ALBALAWI YA, Shull T, Virdi A, Subra C, et al
    CD4dimCD8bright T cells are inversely associated with neuro-inflammatory markers among people living with HIV.
    AIDS. 2023 Oct 4. doi: 10.1097/QAD.0000000000003743.
    PubMed     Abstract available

  75. NOIPERM P, Saelue P
    Predictive model for diagnostic yield of bone marrow examination in patients with HIV infection with fever.
    AIDS. 2023 Oct 4. doi: 10.1097/QAD.0000000000003744.
    PubMed     Abstract available

  76. DIRAJLAL-FARGO S, Strah M, Ailstock K, Sattar A, et al
    Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV.
    AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003741.
    PubMed     Abstract available

  77. JOSHU CE, Calkins KL, Rudolph JE, Xu X, et al
    Lower endoscopy, early-onset and average-onset colon cancer among medicaid beneficiaries with and without HIV: A cohort study.
    AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003740.
    PubMed     Abstract available

  78. SHEIRA LA, Wekesa P, Cohen CR, Weke E, et al
    Impact of a livelihood intervention on gender roles and relationship power among people living with HIV.
    AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003742.
    PubMed     Abstract available

  79. GANDHI MM, Nguyen KL, Lake JE, Liao D, et al
    Proprotein convertase subtisilin/kexin 9 (PCSK9) levels decline with HCV therapy in people with HIV/HCV and correlate with inflammation.
    AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003739.
    PubMed     Abstract available

  80. POURCHER V, Tubach F, Rozes A, Boussouar S, et al
    Outcomes of coronavirus disease 2019-related hospitalization among people with HIV: historical cohort from the Greater Paris area multicenter hospital data warehouse.
    AIDS. 2023;37:1915-1917.

  81. TOWNES A, Kota KK, Dailey AF, Henny KD, et al
    Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017-2021.
    AIDS. 2023;37:1912-1914.
    PubMed     Abstract available

  82. SUN J, Liu L, Chen J, Wang Z, et al
    Zanubrutinib, lenalidomide, and rituximab (ZR2 regimen) for HIV-associated diffuse large B-cell lymphoma: a real-world analysis from China.
    AIDS. 2023;37:1909-1911.
    PubMed     Abstract available

  83. LEE D
    The importance of exercise and physical activity in older adults with HIV.
    AIDS. 2023;37:1905-1907.

  84. MCCRARY LM, Solomon DA
    Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action.
    AIDS. 2023;37:1901-1903.

  85. NIYONGABO B, Hira S
    Evaluation of the diagnostic efficacy of EC-test for latent tuberculosis infection in ambulatory people with HIV.
    AIDS. 2023;37:1899-1900.

  86. VENTER F, Niyongabo B
    Tuberculosis-HIV co-infection in an era of complex, rapid new drug development.
    AIDS. 2023;37:1897-1898.

  87. FILIP I
    Accelerated vascular aging in people with HIV: how can we slow down the clock?
    AIDS. 2023;37:N11.

  88. ROSENTHAL ES, Brokus C, Sun J, Carpenter JE, et al
    Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections.
    AIDS. 2023;37:1799-1809.
    PubMed     Abstract available

    September 2023
  89. NUNES MC, Tamblyn A, Jose L, Ntsimane M, et al
    Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003731.
    PubMed     Abstract available

  90. PARRA-RODRIGUEZ L, O'halloran J, Wang Y, Jin W, et al
    Common antiretroviral combinations are associated with somatic depressive symptoms in women with HIV.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003730.
    PubMed     Abstract available

  91. ONYANGO DO, van der Sande MAB, Yuen CM, Were J, et al
    Biomarker-confirmed suboptimal adherence to isoniazid preventive therapy among children living with HIV in western Kenya.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003719.
    PubMed     Abstract available

  92. KILLION JA, Magana C, Cepeda JA, Vo A, et al
    Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003718.
    PubMed     Abstract available

  93. RACCAGNI AR, Diotallevi S, Lolatto R, Lucente MF, et al
    Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
    AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003733.
    PubMed     Abstract available

  94. DAVEY DLJ, Nyemba DC, Mvududu R, Mashele N, et al
    Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa: an observational cohort study.
    AIDS. 2023 Sep 18. doi: 10.1097/QAD.0000000000003729.
    PubMed     Abstract available

  95. SLOGROVE AL, Bovu A, de Beer S, Phelanyane F, et al
    Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa: population-based cohort study.
    AIDS. 2023 Sep 15. doi: 10.1097/QAD.0000000000003728.
    PubMed     Abstract available

  96. LAVOIE MC, Koech E, Blanco N, Wangusi R, et al
    Factors associated with enrollment into differentiated service delivery model among adults living with HIV in Kenya.
    AIDS. 2023 Sep 14. doi: 10.1097/QAD.0000000000003725.
    PubMed     Abstract available

  97. VAN PAASSEN PM, van Pul L, van der Straten K, Buchholtz NVJE, et al
    Virological and immunological correlates of HIV post-treatment control after temporal antiretroviral therapy during acute HIV infection.
    AIDS. 2023 Sep 12. doi: 10.1097/QAD.0000000000003722.
    PubMed     Abstract available

  98. BURNETT JC, Broz D, Berg J, Callens S, et al
    Using serial cross-sectional surveys to create a retrospective nested cohort to determine HIV incidence from 20 U.S. Cities - 2008-2019.
    AIDS. 2023 Sep 12. doi: 10.1097/QAD.0000000000003724.
    PubMed     Abstract available

  99. WAN MM, Gill MJ, Fonseca K, Krentz H, et al
    Neurologic infections in people with HIV: shifting epidemiological and clinical patterns.
    AIDS. 2023 Sep 12. doi: 10.1097/QAD.0000000000003723.
    PubMed     Abstract available

  100. GATECHOMPOL S, Kerr SJ, Cardoso SW, Samaneka W, et al
    Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation.
    AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003713.
    PubMed     Abstract available

  101. HONG H, Dill-Mcfarland KA, Benson B, Simmons JD, et al
    Mtb-induced Monocyte Transcriptional Responses Associate with Resistance to TST/IGRA Conversion in PLWH.
    AIDS. 2023 Sep 11. doi: 10.1097/QAD.0000000000003716.
    PubMed     Abstract available

  102. MUSTANSKI B, Ryan DT, Spinelli MA, Gandhi M, et al
    Urine point-Of-care tenofovir test demonstrates strong predictive clinical and research utility.
    AIDS. 2023 Sep 6. doi: 10.1097/QAD.0000000000003710.
    PubMed     Abstract available

  103. MARCUS ME, Mahlalela N, Drame ND, Rohr JK, et al
    Home-based HIV testing strategies for middle-aged and older adults in rural South Africa: a randomized controlled trial.
    AIDS. 2023 Sep 6. doi: 10.1097/QAD.0000000000003698.
    PubMed     Abstract available

  104. CHEN RQ, Zino L, Geerlings S, Colbers A, et al
    Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass.
    AIDS. 2023;37:1769-1771.

  105. HOVE-SKOVSGAARD M, Hogh J, Pham MHC, Knudsen AD, et al
    Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV.
    AIDS. 2023;37:1765-1767.
    PubMed     Abstract available

  106. WATERS L, Woolley I
    More evidence for inequitable COVID-19 outcomes in people with HIV.
    AIDS. 2023;37:1763-1764.

    Is there a link between antiretroviral therapy and hypertensive disorders of pregnancy?
    AIDS. 2023;37:1759-1761.

    A new look at human leukocyte antigen variation in HIV; functional clustering to enhance power for discovery of host genetic associations.
    AIDS. 2023;37:1757-1758.

  109. ZUCCO AG, Bennedbaek M, Ekenberg C, Gabrielaite M, et al
    Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.
    AIDS. 2023;37:1643-1650.
    PubMed     Abstract available

  110. FILIP I
    Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston.
    AIDS. 2023;37:N9-N10.

    August 2023
  111. SHELTON BA, Sawinski D, Peter I, Maclennan PA, et al
    African American/black race, Apolipoprotein L1, and the indirect glomerular filtration measure serum creatinine among persons living with HIV.
    AIDS. 2023 Aug 31. doi: 10.1097/QAD.0000000000003708.
    PubMed     Abstract available

  112. BALASUBRAMANIAN R, Shearer K, Mudzengi D, Hippner P, et al
    Modeling the impact of universal TB molecular testing and timing of TB preventive treatment during ART initiation in South Africa.
    AIDS. 2023 Aug 30. doi: 10.1097/QAD.0000000000003707.
    PubMed     Abstract available

  113. CHAKRAVARTY J, Reddy S, Gupta MK, Tilak R, et al
    Screening for cryptococcal antigen in asymptomatic PLHIV: an urgent need in Eastern India.
    AIDS. 2023 Aug 25. doi: 10.1097/QAD.0000000000003702.
    PubMed     Abstract available

  114. MCCORMICK CD, Sullivan PS, Qato DM, Crawford SY, et al
    Trends of non-occupational post-exposure prophylaxis (nPEP) in the United States.
    AIDS. 2023 Aug 25. doi: 10.1097/QAD.0000000000003701.
    PubMed     Abstract available

  115. LAI M, Scherzer R, Shlipak MG, Madden E, et al
    Ambulatory urine biomarkers associations with AKI and hospitalization in people with HIV: predictors of acute renal injury study (PARIS).
    AIDS. 2023 Aug 25. doi: 10.1097/QAD.0000000000003705.
    PubMed     Abstract available

  116. FERREIRA MP, Thuler LCS, Bergmann A, Soares EA, et al
    Differential survival of Brazilian patients with diffuse large B-cell lymphoma with and without HIV infection.
    AIDS. 2023 Aug 25. doi: 10.1097/QAD.0000000000003700.
    PubMed     Abstract available

  117. PERAZZOLO S, Stephen Z, Eguchi M, Xu X, et al
    A novel formulation enabled transformation of 3 HIV drugs tenofovir-lamivudine-dolutegravir (TLD) from short-acting to long-acting all-in-one injectable.
    AIDS. 2023 Aug 25. doi: 10.1097/QAD.0000000000003706.
    PubMed     Abstract available

  118. MOTTA E, Camacho LAB, Cunha M, de Filippis AB, et al
    Immunogenicity and reactogenicity of yellow fever vaccine in people living with HIV.
    AIDS. 2023 Aug 24. doi: 10.1097/QAD.0000000000003696.
    PubMed     Abstract available

  119. NICHOLLS EJ, Policek N, Volny-Anne A, Spire B, et al
    A systematic review of qualitative research on recently-acquired HIV.
    AIDS. 2023 Aug 24. doi: 10.1097/QAD.0000000000003697.
    PubMed     Abstract available

  120. FREEMAN MC, Wainberg ML, Slabbert JD, Mabela S, et al
    Persons with severe mental health conditions should be included as a key population in HIV programmes - a case study of South Africa.
    AIDS. 2023 Aug 18. doi: 10.1097/QAD.0000000000003692.

  121. VAN PUL L, Maurer I, Boeser-Nunnink BDM, Harskamp AM, et al
    A genetic variation in Fucosyltransferase 8 accelerates HIV-1 disease progression indicating a role for N-glycan fucosylation.
    AIDS. 2023 Aug 18. doi: 10.1097/QAD.0000000000003689.
    PubMed     Abstract available

  122. KOUAMOU V, Gundidza P, Ndhlovu CE, Makadzange AT, et al
    Factors associated with CD4 cell count recovery among males and females with advanced HIV disease.
    AIDS. 2023 Aug 18. doi: 10.1097/QAD.0000000000003695.
    PubMed     Abstract available

  123. KANITKAR T, Dissanayake O, Bakewell N, Symonds M, et al
    Changes in short-term (in-ICU and in-hospital) mortality following Intensive Care Unit admission in adults Living with HIV: 2000-2019.
    AIDS. 2023 Aug 10. doi: 10.1097/QAD.0000000000003683.
    PubMed     Abstract available

  124. SINGH K, Natarajan V, Dewar R, Rupert A, et al
    Long-term persistence of transcriptionally-active "defective" HIV-1 proviruses: Implications for persistent immune activation during antiretroviral therapy.
    AIDS. 2023 Aug 8. doi: 10.1097/QAD.0000000000003667.
    PubMed     Abstract available

  125. BENGTSON AM, Madlala H, Matjila MJ, Levitt N, et al
    Associations of HIV and antiretroviral therapy with gestational diabetes: findings from a prospective cohort in South Africa.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003678.
    PubMed     Abstract available

  126. COSTINIUK CT, Singer J, Lee T, Galipeau Y, et al
    Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328).
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003680.
    PubMed     Abstract available

  127. MAKINSON A, Allavena C, Abulizi X, Slama L, et al
    Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003681.
    PubMed     Abstract available

  128. MATOGA M, Chen JS, Massa C, Thengolose I, et al
    HIV and urethritis: Time required for antiretroviral therapy to suppress HIV in semen.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003679.
    PubMed     Abstract available

  129. MASICH AM, Gomes D, Higginson RT, Morgan Z, et al
    HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program.
    AIDS. 2023;37:1641-1642.

  130. Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe.
    AIDS. 2023;37:1633-1639.
    PubMed     Abstract available

  131. WASHAYA T, Manasa J, Kouamou V
    HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings.
    AIDS. 2023;37:1629-1631.

  132. AHMAD A, Samarani S, Costiniuk CT
    Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters.
    AIDS. 2023;37:1625-1627.

  133. FILIP I
    Evolving relationship between HIV infection and inflammatory bowel disease adds layer of complexity to HIV management.
    AIDS. 2023;37:N7-N8.

    July 2023
  134. KRAEF C, Bentzon A, Roen A, Bolokadze N, et al
    Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003670.
    PubMed     Abstract available

  135. CHUN HM, Milligan K, Boyd MA, Abutu A, et al
    Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003672.
    PubMed     Abstract available

  136. JONGEN VW, Loeff MFSV, Van Den Elshout M, Wijstma E, et al
    Bacterial sexually transmitted infections are concentrated in subpopulations of MSM using HIV PrEP: an analysis of longitudinal trajectories.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003676.
    PubMed     Abstract available

  137. LAKE JE, Taron J, Ribaudo HJ, Leon-Cruz J, et al
    Hepatic steatosis and NAFLD are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003671.
    PubMed     Abstract available

  138. GUHA D, Misra V, Yin J, Horiguchi M, et al
    Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy.
    AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003675.
    PubMed     Abstract available

  139. MCLAUGHLIN MM, Durstenfeld MS, Gandhi M, Greene M, et al
    Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease.
    AIDS. 2023 Jul 27. doi: 10.1097/QAD.0000000000003666.
    PubMed     Abstract available

  140. GAO H, Zhang J, Yang X, Chen S, et al
    The incidence and dynamic risk factors of chronic kidney disease among people living with HIV - A population-based Cohort Study.
    AIDS. 2023 Jul 19. doi: 10.1097/QAD.0000000000003662.
    PubMed     Abstract available

  141. HONGE BL, Andersen MN, Petersen MS, Jespersen S, et al
    Monocyte phenotype and extracellular vesicles in HIV-1, HIV-2, and HIV-1/2 dual infection.
    AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003660.
    PubMed     Abstract available

  142. DICKEY BL, Putney RM, Suneja G, Kresovich JK, et al
    Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer.
    AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003661.
    PubMed     Abstract available

  143. MUULA GK, Bosomprah S, Sinkala E, Nsokolo B, et al
    HBV viral replication markers and hepatic fibrosis in untreated chronic HBV infection with and without HIV coinfection in Zambia.
    AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003659.
    PubMed     Abstract available

  144. MARTINELLO M, Carson JM, Van Der Valk M, Rockstroh JK, et al
    Reinfection incidence and risk among people treated for recent hepatitis C virus infection: the react study.
    AIDS. 2023 Jul 18. doi: 10.1097/QAD.0000000000003651.
    PubMed     Abstract available

  145. Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum.
    AIDS. 2023;37:1495.

  146. SCHWARTZ M, Balkrishnan R
    Impacts of religious liberty court case outcomes on pre-exposure prophylaxis accessibility for Medicaid beneficiaries.
    AIDS. 2023;37:1493-1494.

  147. REZZONICO LF, Baldassari L, Peracchi F, Merli M, et al
    Use of long-acting cabotegravir + rilpivirine during hemodialysis and solid organ transplantation.
    AIDS. 2023;37:1491-1493.

  148. ROSEN JG, Reynolds SJ, Galiwango RM, Kigozi G, et al
    A moving target: impacts of lowering viral load suppression cutpoints on progress towards HIV epidemic control goals.
    AIDS. 2023;37:1486-1489.
    PubMed     Abstract available

  149. VERBURGH ML, van der Valk M, Rijnders BJA, Reiss P, et al
    No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands.
    AIDS. 2023;37:1481-1486.
    PubMed     Abstract available

  150. FRIEDMAN MR, Kay ES, Maclin BJ, Hawk ME, et al
    Housing is harm reduction.
    AIDS. 2023;37:1477-1479.

    Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people.
    AIDS. 2023;37:1473-1475.

  152. MCCLUSKEY SM, Siedner MJ
    Is it time to make 'undetectable for all' the global standard for HIV care?
    AIDS. 2023;37:1471-1472.

  153. MILIC J, Erlandson KM, Guaraldi G
    Moving from the prediction of fractures to the prediction of falls in an aging HIV scenario.
    AIDS. 2023;37:1467-1469.

  154. PALICH R, Hentzien M, Hocqueloux L, Duvivier C, et al
    Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people living with HIV in France.
    AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003657.
    PubMed     Abstract available

  155. DINH S, Malmstrom S, Moller IK, Yilmaz A, et al
    Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era: a nation-wide population-based study.
    AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003658.
    PubMed     Abstract available

  156. MYSTAKELIS HA, Wilson E, Laidlaw E, Poole A, et al
    An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV.
    AIDS. 2023 Jul 14. doi: 10.1097/QAD.0000000000003656.
    PubMed     Abstract available

  157. VERBURGH ML, Wit FWNM, Boyd A, Reiss P, et al
    No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain.
    AIDS. 2023 Jul 11. doi: 10.1097/QAD.0000000000003654.
    PubMed     Abstract available

  158. SELLIER P, Alexandre-Castor G, Brun A, Hamet G, et al
    Updated mortality and causes of death in 2020-2021 in people living with HIV: a multicenter study in France.
    AIDS. 2023 Jul 10. doi: 10.1097/QAD.0000000000003645.
    PubMed     Abstract available

  159. ROCKSTROH J, Laut KG, Jakobsen SF, Raben D, et al
    An opinion piece on how we move towards common European standards of care for people living with HIV.
    AIDS. 2023 Jul 10. doi: 10.1097/QAD.0000000000003652.

  160. HE J, Ding Y, Lin H, Liu X, et al
    Differential genome-wide associated variants and enriched pathways of electrocardiogram parameters among people with versus without HIV.
    AIDS. 2023 Jul 7. doi: 10.1097/QAD.0000000000003647.
    PubMed     Abstract available

  161. ESBER AL, Dear NF, King D, Francisco LV, et al
    Achieving the 3rd 95 in sub-saharan Africa: application of machine learning approaches to predict viral failure.
    AIDS. 2023 Jul 7. doi: 10.1097/QAD.0000000000003646.
    PubMed     Abstract available

  162. SHIKUMA CM, Wojna V, De Gruttola V, Siriwardhana C, et al
    Impact of ART intensification with CCR5 antagonist maraviroc on HIV-associated neurocognitive impairment.
    AIDS. 2023 Jul 7. doi: 10.1097/QAD.0000000000003650.
    PubMed     Abstract available

  163. ANGEL JB, Freilich J, Arthurs E, Ban JK, et al
    Adherence to oral antiretroviral therapy in Canada, 2010-2020: A retrospective analysis of claims data.
    AIDS. 2023 Jul 7. doi: 10.1097/QAD.0000000000003648.
    PubMed     Abstract available

  164. HAZRA A, Landovitz RJ, Marzinke MA, Quinby C, et al
    Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis.
    AIDS. 2023 Jul 4. doi: 10.1097/QAD.0000000000003644.
    PubMed     Abstract available

  165. DIETRICH DK, Laidlaw E, Hammoud DA, Pau AK, et al
    Dramatic Improvement of MRI Abnormalities of HIV Encephalopathy after Suppressive Antiretroviral Therapy.
    AIDS. 2023;37:1339-1340.

  166. MASENGA SK, Muchaili L, Hamooya BM
    Cardiovascular Outcomes Among Persons with HIV and Nonalcoholic Fatty Liver Disease.
    AIDS. 2023;37:1329-1331.

  167. XIE Y, Wang C, An Q, Wang D, et al
    Glottic Kaposi's sarcoma.
    AIDS. 2023;37:1343-1344.

  168. JIANG R, Sun J, Zhao B, Zhang R, et al
    Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV.
    AIDS. 2023;37:1341-1342.

  169. WOOD BR, Simon GL
    Does Pneumocystis jirovecii pneumonia cause long-term deficits in lung function?
    AIDS. 2023;37:1333-1334.

  170. SOUDEYNS H, Quach C
    Keeping up with Streptococcus pneumoniae in children living with HIV.
    AIDS. 2023;37:1325-1327.

  171. MATOVU FK, Kateera BA
    Association between low bone mass and fracture prevalence among children living with HIV in Africa.
    AIDS. 2023;37:1323-1324.

  172. FILIP I
    HIV-positive donor hearts - a game changer for patients with HIV and organ failure?
    AIDS. 2023;37:N1-N2.

    June 2023
  173. TUKEMAN GL, Wei H, Finnell RH, Cabrera RM, et al
    Dolutegravir induced neural tube defects in mice are folate responsive.
    AIDS. 2023 Jun 29. doi: 10.1097/QAD.0000000000003639.
    PubMed     Abstract available

  174. MUTEMBO S, Yang Y, Carcelen A, Winter AK, et al
    Measles immunity gaps among children and adolescents with HIV in zambia despite high measles vaccination and antiretroviral therapy coverage.
    AIDS. 2023 Jun 29. doi: 10.1097/QAD.0000000000003634.
    PubMed     Abstract available

  175. WEBEL AR, Davey CH, Oliveira V, Cleveland D, et al
    Physical activity is associated with adiposity in older adults with HIV in the modern HIV era.
    AIDS. 2023 Jun 28. doi: 10.1097/QAD.0000000000003635.
    PubMed     Abstract available

  176. MA Y, Zhang J, Yang X, Chen S, et al
    Association of CD4 count and HIV viral load with risk of Non-AIDS-defining cancers.
    AIDS. 2023 Jun 28. doi: 10.1097/QAD.0000000000003637.
    PubMed     Abstract available

  177. DU M, Wang Y, Qin C, Mi D, et al
    Prevalence and incidence of stroke among people living with HIV: a systematic review and meta-analysis.
    AIDS. 2023 Jun 22. doi: 10.1097/QAD.0000000000003632.
    PubMed     Abstract available

  178. GRAY RT, Camara H, Khawar L, Grulich A, et al
    The application of new metrics for understanding trends in undiagnosed HIV among key populations.
    AIDS. 2023 Jun 22. doi: 10.1097/QAD.0000000000003630.
    PubMed     Abstract available

  179. MASSMANN R, Groh T, Jilich D, Bartkova D, et al
    HIV-positive Ukrainian refugees in the Czech Republic: a retrospective, observational study.
    AIDS. 2023 Jun 22. doi: 10.1097/QAD.0000000000003633.
    PubMed     Abstract available

  180. LURAIN K, Polizzotto MN, Krug LT, Shoemaker G, et al
    Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
    AIDS. 2023 Jun 20. doi: 10.1097/QAD.0000000000003627.
    PubMed     Abstract available

  181. ABELMAN RA, Fitzpatrick J, Zawedde J, Sanyu I, et al
    Sex modifies the risk of HIV-associated obstructive lung disease in ugandans post-pneumonia.
    AIDS. 2023 Jun 20. doi: 10.1097/QAD.0000000000003626.
    PubMed     Abstract available

  182. FISHER MC, Hoover DR, Shi Q, Sharma A, et al
    Association of marijuana, tobacco and alcohol use with estimated glomerular filtration rate in women living with HIV and women without HIV.
    AIDS. 2023 Jun 20. doi: 10.1097/QAD.0000000000003625.
    PubMed     Abstract available

  183. FERGUSON L, Gruskin S, Bolshakova M, Rozelle M, et al
    Systematic review and quantitative and qualitative comparative analysis of interventions to address HIV-related stigma and discrimination.
    AIDS. 2023 Jun 20. doi: 10.1097/QAD.0000000000003628.
    PubMed     Abstract available

  184. TRIANA-GONZALEZ S, Roman-Lopez C, Mauss S, Cano-Diaz AL, et al
    Risk factors for mortality and clinical presentation of Monkeypox: a prospective cohort study in a HIV reference center.
    AIDS. 2023 Jun 9. doi: 10.1097/QAD.0000000000003623.
    PubMed     Abstract available

  185. PINTYE J, Kinuthia J, Abuna F, Anderson PL, et al
    PrEP initiation, persistence, and adherence during pregnancy through the postpartum period: a prospective analysis in Kenya.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003617.
    PubMed     Abstract available

  186. SMITH C, Silveira L, Crotteau M, Garth K, et al
    Modern antiretroviral regimens in pregnant women: virologic outcomes and durability.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003616.
    PubMed     Abstract available

  187. TORRE P 3RD, Sundermann EE, Brandino A, Heaton A, et al
    Auditory and cognitive function in older adults living with and without HIV.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003618.
    PubMed     Abstract available

  188. RICH SN, Cook RL, Mavian CN, Garrett K, et al
    Network typologies predict future molecular linkages in the network of HIV transmission in Florida.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003621.
    PubMed     Abstract available

  189. RAMETSE CL, Webb EL, Herrera C, Alinde B, et al
    A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003619.
    PubMed     Abstract available

  190. BARTHOLD D, Saldarriaga EM, Brah AT, Hauber B, et al
    Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV.
    AIDS. 2023 Jun 7. doi: 10.1097/QAD.0000000000003620.
    PubMed     Abstract available

  191. WARNER NC, Shishido A, Fulco PP, Sastry S, et al
    Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS.
    AIDS. 2023;37:1187-1188.

  192. LEES EA, Tickner N, Lyall H, Mcmaster P, et al
    Infant postnatal prophylaxis following maternal viraemia during breastfeeding.
    AIDS. 2023;37:1185-1186.

  193. ROGER PM, Perre PV
    l-Carnitine for immunological nonresponders to efficient antiretroviral therapy.
    AIDS. 2023;37:1183-1185.

  194. LAGOUTTE-RENOSI J, Karsenty J, Martha B, Davani S, et al
    Management of a drug-drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma.
    AIDS. 2023;37:1181-1183.

  195. BLOWER S, Okano JT, Kahn JS
    Modeling UNAIDS treatment targets for China.
    AIDS. 2023;37:1175-1176.

  196. ROUTY JP, Isnard S
    An army marches on its stomach: immunometabolic dysregulation in persons with HIV.
    AIDS. 2023;37:1171-1173.

  197. PENCE BW, Gaynes BN
    Time to get it right: investing in the mental wellbeing of people living with HIV.
    AIDS. 2023;37:1167-1169.

  198. SLAMA L, Hardy WD, Quinones-Mateu ME, Kuritzkes DR, et al
    Alternative options for treatment-experienced people with HIV.
    AIDS. 2023;37:1165-1166.

  199. NGUYEN NN, Winslow DL
    Complexities of rifamycin use in persons with HIV infection.
    AIDS. 2023;37:1161-1163.

  200. ZACCARELLI M, Niyongabo B, Conway B
    Point-of-care urine tenofovir testing: making a good thing better.
    AIDS. 2023;37:1159-1160.

    Getting acute HIV infection under control.
    AIDS. 2023;37:1157-1158.

  202. SCHNEIDER J, Coutinho R, Hatcher AM, Larmarange J, et al
    Stimulating dissemination of research that addresses the social and contextual drivers of HIV prevention and treatment in the journal AIDS.
    AIDS. 2023;37:1021.

  203. TANG ME, Goyal R, Anderson CM, Mehta SR, et al
    Assessing the reliability of the CD4 depletion model in the presence of ending the HIV epidemic initiatives.
    AIDS. 2023 Jun 1. doi: 10.1097/QAD.0000000000003614.
    PubMed     Abstract available

  204. SHUBIN Z, Stanfield-Oakley S, Puangkaew J, Pitisutthithum P, et al
    Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector functions magnitude but not durability.
    AIDS. 2023 Jun 1. doi: 10.1097/QAD.0000000000003611.
    PubMed     Abstract available

    May 2023
  205. HAHN JA, Ngabirano C, Fatch R, Emenyonu NI, et al
    Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use: a single arm trial.
    AIDS. 2023 May 30. doi: 10.1097/QAD.0000000000003613.
    PubMed     Abstract available

  206. GELPI M, Karvig LU, Knudsen AD, Sorensen EW, et al
    Incidence of hypertension in people with HIV infection: a longitudinal observational study.
    AIDS. 2023 May 25. doi: 10.1097/QAD.0000000000003609.
    PubMed     Abstract available

  207. YEE LM, Jacobson DL, Haddad LB, Jao J, et al
    Evaluating the association of antiretroviral therapy and immune status with hypertensive disorders of pregnancy among people with HIV.
    AIDS. 2023 May 24. doi: 10.1097/QAD.0000000000003607.
    PubMed     Abstract available

  208. WIT FW, Reiss P, Rijnders B, Rokx C, et al
    COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study.
    AIDS. 2023 May 19. doi: 10.1097/QAD.0000000000003597.
    PubMed     Abstract available

  209. CRICHTON S, Jesson J, Ake-Assi MH, Belfrage E, et al
    Global variations in pubertal growth spurts in adolescents living with perinatal HIV.
    AIDS. 2023 May 18. doi: 10.1097/QAD.0000000000003602.
    PubMed     Abstract available

  210. RAHIM FO, Jain B, Bloomfield GS, Jain P, et al
    A Holistic framework to integrate HIV and cardiovascular disease care in sub-saharan Africa.
    AIDS. 2023 May 17. doi: 10.1097/QAD.0000000000003604.

  211. KAMITANI E, Mizuno Y, DeLuca JB, Collins CB, et al
    Systematic review of alternative HIV pre-exposure prophylaxis (PrEP) care delivery models to improve PrEP services.
    AIDS. 2023 May 15. doi: 10.1097/QAD.0000000000003601.
    PubMed     Abstract available

  212. ZEULI JD, Rivera CG, Wright JA, Kasten MJ, et al
    Pharmacogenomic panel testing provides insight and enhances medication management in persons living with HIV.
    AIDS. 2023 May 12. doi: 10.1097/QAD.0000000000003598.
    PubMed     Abstract available

  213. KUHN L, Wang T, Li F, Strehlau R, et al
    Microbiota in the oral cavity of school-age children living with HIV who started antiretroviral therapy at young ages in South Africa.
    AIDS. 2023 May 12. doi: 10.1097/QAD.0000000000003599.
    PubMed     Abstract available

  214. LUO K, Wang Z, Peters BA, Hanna DB, et al
    Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection.
    AIDS. 2023 May 12. doi: 10.1097/QAD.0000000000003596.
    PubMed     Abstract available

  215. CHALOUNI M, Trickey A, Ingle SM, Sepuvelda MA, et al
    Impact of Hepatitis C cure on risk of mortality and morbidity in people with HIV after ART initiation.
    AIDS. 2023 May 10. doi: 10.1097/QAD.0000000000003594.
    PubMed     Abstract available

  216. WILCOX DR, Rudmann EA, Ye E, Noori A, et al
    Cognitive concerns are a risk factor for mortality in people with human immunodeficiency virus and COVID-19.
    AIDS. 2023 May 10. doi: 10.1097/QAD.0000000000003595.
    PubMed     Abstract available

  217. AUGELLO M, Bono V, Rovito R, Tincati C, et al
    Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection.
    AIDS. 2023 May 5. doi: 10.1097/QAD.0000000000003585.
    PubMed     Abstract available

  218. WISE JM, Jackson EA, Kempf MC, Oates GR, et al
    Sex differences in incident atherosclerotic cardiovascular disease events among women and men living with HIV.
    AIDS. 2023 May 4. doi: 10.1097/QAD.0000000000003592.
    PubMed     Abstract available

  219. BURGOS J, Campany D, Garcia J, Landolfi S, et al
    Effectiveness of topical cidofovir for treatment of refractory anal high-grade squamous intraepithelial lesion (HSIL).
    AIDS. 2023 May 4. doi: 10.1097/QAD.0000000000003591.
    PubMed     Abstract available

  220. Real world use of dolutegravir two drug regimens: Erratum.
    AIDS. 2023;37:1019.

  221. ZHOU Z, Feng Y, Ou W, Zhang D, et al
    Inference of HIV-1 transmission direction between men who have sex with men (MSM) and their wives in China.
    AIDS. 2023;37:1015-1017.

  222. VASHISHT R, Tilak TVSVGK, Arivalagan B, Kashif AW, et al
    Carcinoid syndrome in a HIV-infected patient: where you least expect it.
    AIDS. 2023;37:1013-1015.

  223. GUARALDI G, Milic J
    Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?
    AIDS. 2023;37:1005-1008.

  224. WHITE CJ, Goodkin K
    Bioenergetics and neuroimaging research: a neuropathophysiological linkage in the setting of cocaine use amongst persons with HIV.
    AIDS. 2023;37:1001-1003.

  225. DUDE A
    Pregnant patients living with HIV and antiretroviral therapy selection: consider the effect on gestational weight gain.
    AIDS. 2023;37:999-1000.

  226. JOHNSTON CD, O'Brien R, Cote HCF
    Inclusion of women in HIV research and clinical trials.
    AIDS. 2023;37:995-997.

    Sleep and mood disturbances in people with HIV remain largely understudied.
    AIDS. 2023;37:993-994.

  228. STEEGEN K, Chandiwana N, Sokhela S, Venter WDF, et al
    Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries.
    AIDS. 2023;37:1009-1011.
    PubMed     Abstract available

    April 2023
  229. ZHANG YQ, Li QH, Li EL, Wang YR, et al
    Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among men who have sex with men in China.
    AIDS. 2023 Apr 25. doi: 10.1097/QAD.0000000000003589.
    PubMed     Abstract available

  230. PALICH R, Hentzien M, Hocqueloux L, Duvivier C, et al
    Country of birth is associated with antiretroviral therapy choice in treatment-naive persons living with HIV in France.
    AIDS. 2023 Apr 21. doi: 10.1097/QAD.0000000000003588.
    PubMed     Abstract available

  231. JOSEPH JT, Mpasela F, Dowling S, Banda I, et al
    Optimizing and validating a pediatric screening tool to more efficiently test and identify children living with HIV.
    AIDS. 2023 Apr 21. doi: 10.1097/QAD.0000000000003583.
    PubMed     Abstract available

  232. ZHU T, Cao W, Li T
    HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive ART.
    AIDS. 2023 Apr 21. doi: 10.1097/QAD.0000000000003587.
    PubMed     Abstract available

  233. CHONGXING Z, Yuanchun L, Yan H, Dabin L, et al
    Evaluation of the Diagnostic Efficacy of EC-Test for Latent Tuberculosis Infection in Ambulatory People Living with HIV.
    AIDS. 2023 Apr 20. doi: 10.1097/QAD.0000000000003573.
    PubMed     Abstract available

  234. FREDERIX K, Schwitters A, Chung G, Mccracken S, et al
    The state of the pediatric HIV epidemic in Lesotho: results from a population-based survey.
    AIDS. 2023 Apr 19. doi: 10.1097/QAD.0000000000003581.
    PubMed     Abstract available

  235. MARTYN-DICKENS C, Ojewale O, Sly-Moore E, Dompreh A, et al
    Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003576.
    PubMed     Abstract available

  236. LI MJ, Chau B, Garland WH, Oksuzyan S, et al
    Racial, gender, and psychosocial disparities in viral suppression trends among people receiving coordinated HIV care in Los Angeles County.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003578.
    PubMed     Abstract available

  237. GRIFFIN DW, Pai Mangalore R, Hoy JF, Mcmahon JH, et al
    Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis.
    AIDS. 2023 Apr 14. doi: 10.1097/QAD.0000000000003579.
    PubMed     Abstract available

  238. ZHANG Z, Duri K, Duisters KLW, Schoeman JC, et al
    Altered methionine-sulfone levels are associated with impaired growth in HEU-children.
    AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003574.
    PubMed     Abstract available

  239. TEBAS P, Lynn K, Azzoni L, Cocchella G, et al
    Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons.
    AIDS. 2023 Apr 12. doi: 10.1097/QAD.0000000000003575.
    PubMed     Abstract available

  240. SADA YH, da Costa WL Jr, Kramer JR, Chiao EY, et al
    Survival outcomes in Veterans with hepatocellular carcinoma, with and without HIV infection.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003568.
    PubMed     Abstract available

  241. REDDON H, Fairbairn N, Grant C, Milloy MJ, et al
    Experiencing homelessness and progression through the HIV cascade of care among people who use drugs.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003570.
    PubMed     Abstract available

  242. RUBIN LH, Du Y, Sweeney SE, O'Toole R, et al
    Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003572.
    PubMed     Abstract available

  243. MARAGH-BASS AC, Stoner M, Castellanos-Usigli A, Agarwal H, et al
    New PrEP options need different counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities (YSGM) of color.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003563.

  244. RIVERA AS, Rusie LK, Feinstein MJ, Siddique J, et al
    Intersectionality-informed analysis of durable viral suppression disparities in people with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003565.
    PubMed     Abstract available

  245. REQUENA MB, Grabar S, Lanoy E, Pialoux G, et al
    Mortality in HCV-cured versus HCV-uninfected people with HIV: a matched analysis in the ANRS CO4 FHDH cohort.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003569.
    PubMed     Abstract available

  246. WOMACK JA, Murphy TE, Leo-Summers L, Kidwai-Khan F, et al
    Performance of a modified fracture risk assessment tool (FRAX) for fragility fracture prediction among older veterans living with HIV.
    AIDS. 2023 Apr 6. doi: 10.1097/QAD.0000000000003566.
    PubMed     Abstract available

  247. Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: Erratum.
    AIDS. 2023;37:859.

  248. LAURENT C, Hentzien M, Pavel S, Didier K, et al
    Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS.
    AIDS. 2023;37:856-858.

  249. VON TOKARSKI F, Fourn E, Faucheron A, Chan Hew Wai A, et al
    Smallpox vaccine acceptability among French men having sex with men living with HIV in settings of monkeypox outbreak.
    AIDS. 2023;37:855-856.

  250. HU G, Brew BJ
    Extracellular vesicle small noncoding RNAs: a window into pathogenesis and diagnosis.
    AIDS. 2023;37:849-850.

    Estimated glomerular filtration rate equations: one size does not fit all.
    AIDS. 2023;37:845-847.

    A contemporary and inflammatory triangle at the mucosa: HIV, antibodies and bacterial STIs.
    AIDS. 2023;37:841-843.

  253. SU B, Vanham G
    Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals.
    AIDS. 2023;37:837-839.

    March 2023
  254. SCOFIELD D, Weis N, Andersson M, Storgaard M, et al
    Psychosocial, sexual, reproductive and menopausal health in women with and without HIV in a high-income setting.
    AIDS. 2023 Mar 29. doi: 10.1097/QAD.0000000000003555.
    PubMed     Abstract available

  255. GONZALEZ J, Wilson A, Byrd D, Cortes EP, et al
    Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV.
    AIDS. 2023 Mar 29. doi: 10.1097/QAD.0000000000003556.
    PubMed     Abstract available

  256. VARGAS JC, Marques MO, Pereira J, Braga WMT, et al
    Factors associated with survival in patients with lymphoma and HIV: the largest cohort study in Brazil.
    AIDS. 2023 Mar 21. doi: 10.1097/QAD.0000000000003549.
    PubMed     Abstract available

  257. RODRIGUEZ VJ, Alfonso D, VanLandingham H, Kozlova S, et al
    Prevalence of neurodevelopmental delays in infants with perinatal HIV infection in comparison with HIV exposure in rural South Africa.
    AIDS. 2023 Mar 21. doi: 10.1097/QAD.0000000000003553.
    PubMed     Abstract available

  258. IZQUIERDO MIGUEL R, Rava M, Moreno-Garcia E, Blanco JR, et al
    HIV medical care interruption among people living with HIV in Spain, 2004-2020.
    AIDS. 2023 Mar 21. doi: 10.1097/QAD.0000000000003552.
    PubMed     Abstract available

  259. WILCK M, Barnabas S, Chokephaibulkit K, Violari A, et al
    A phase 3 study of safety and immunogenicity of V114, a 15-valent PCV, followed by PPSV23, in children living with HIV.
    AIDS. 2023 Mar 20. doi: 10.1097/QAD.0000000000003551.
    PubMed     Abstract available

  260. MAZZITELLI M, Sasset L, Mengato D, Cattelan A, et al
    I would but I cannot, I can but I do not want: unmet needs of people with HIV in the long-acting era.
    AIDS. 2023;37:707-708.

  261. TENG AE, Hsue PY, Secemsky EA
    Response to correspondence to "Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population".
    AIDS. 2023;37:706.

    Response to "Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population".
    AIDS. 2023;37:705.

  263. HEATH SL, Bansal A
    Mpox infection in people living with HIV.
    AIDS. 2023;37:701-703.

  264. GENER A
    Sparse data obscure an unchecked Russian HIV epidemic.
    AIDS. 2023;37:697-699.

  265. LAURENCE J, Winslow DL
    Distinct inflammatory profiles linked to cardiovascular disease risk in HIV infection: implications for the design of preventive and therapeutic interventions.
    AIDS. 2023;37:693-695.

  266. WOOD BR, Kassaye SG, Gerstoft J
    Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation.
    AIDS. 2023;37:689-691.

  267. GUERVILLE F, Vialemaringe M, Cognet C, Duffau P, et al
    Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis.
    AIDS. 2023 Mar 14. doi: 10.1097/QAD.0000000000003546.
    PubMed     Abstract available

  268. TARAMASSO L, Squillace N, Ricci E, Menzaghi B, et al
    Incident diabetes in course of antiretroviral therapy.
    AIDS. 2023 Mar 14. doi: 10.1097/QAD.0000000000003548.
    PubMed     Abstract available

  269. HARDIAWAN D, Juwita MN, Vadra J, Prawiranegara R, et al
    Cost of improved test and treat strategies in Indonesia: a study of HATI implementation trial.
    AIDS. 2023 Mar 14. doi: 10.1097/QAD.0000000000003547.
    PubMed     Abstract available

  270. LIN SH, Khan SM, Zhou W, Brown DW, et al
    Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma.
    AIDS. 2023 Mar 14. doi: 10.1097/QAD.0000000000003545.
    PubMed     Abstract available

  271. OOMEN PGA, Bronsveld I, Hoepelman AIM, van Welzen BJ, et al
    No long-term effect of past Pneumocystis jirovecii pneumonia on pulmonary function in people with HIV.
    AIDS. 2023 Mar 10. doi: 10.1097/QAD.0000000000003540.
    PubMed     Abstract available

  272. BONACINA S, Niemczak C, Lichtenstein JD, Magohe A, et al
    Pre-literacy assessment in children living with HIV in Tanzania: comparison to results from children living without HIV in Tanzania and the US.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003529.
    PubMed     Abstract available

  273. TEMU TM, Polyak SJ, Wanjalla CN, Mandela NA, et al
    Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003523.
    PubMed     Abstract available

  274. KRISHNAN A, Sims OT, Surapaneni PK, Woreta TA, et al
    Risk of Adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003537.
    PubMed     Abstract available

  275. SHEN M, Xiao Y, Rong L, Zhuang G, et al
    The impact of attrition on the transmission of HIV and drug resistance: A mathematical modelling study.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003528.
    PubMed     Abstract available

  276. DI SANDRO S, Catellani B, Guidetti C, Magistri P, et al
    Successful living donor liver transplantation from an HIV and HCV positive donor: report from the first case in the world.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003533.
    PubMed     Abstract available

  277. KOENIG LJ, Khurana N, Islam MH, Gopalappa C, et al
    Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the united states.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003536.
    PubMed     Abstract available

  278. STERMAN FL, Lalezari JP, Kowalczyk UM, Main DW, et al
    Bictegravir/Emtricitabine/Tenofovir Alafenamide Plus Doravirine in Highly Treatment-Experienced Men With Multidrug-Resistant HIV.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003513.
    PubMed     Abstract available

  279. CHOW DC, Saiki KMW, Siriwardhana C, Lozano-Gerona J, et al
    Increased transmigration of intermediate monocytes associated with atherosclerotic burden in people with HIV on antiretroviral therapy.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003534.
    PubMed     Abstract available

  280. SULLIVAN EV, Zahr NM, Sassoon SA, Pohl KM, et al
    Postural instability in HIV infection: relation to central and peripheral nervous system markers.
    AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003531.
    PubMed     Abstract available

  281. COVID-19 vaccine immunogenicity in people with HIV: Erratum.
    AIDS. 2023;37:559.

  282. HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States: Erratum.
    AIDS. 2023;37:557.

  283. MUNOZ-MUELA E, Ruiz-Mateos E, Gutierrez-Valencia A, Lopez-Cortes LF, et al
    Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion?
    AIDS. 2023;37:554-555.

  284. LUO Z, Jiang W
    Reply to: Anti-CD4+ autoantibodies in immunological non-responder people with HIV: cause of CD4+ T-cell depletion?
    AIDS. 2023;37:553-554.

  285. WOOLLEY I, Boccara F
    Primary cardiovascular prevention in people with HIV: what's the score?
    AIDS. 2023;37:547-548.

  286. LYALL H, Cote H, Flynn PM
    Days and weeks do matter: a call for testing infants at risk of HIV acquisition at birth.
    AIDS. 2023;37:545-546.

  287. FICHTENBAUM CJ, Mallon P
    Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?
    AIDS. 2023;37:541-543.

  288. DASGUPTA S, Beer L, Lu JF, Weiser J, et al
    Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015-2020.
    AIDS. 2023;37:535-540.
    PubMed     Abstract available

  289. DAVIES C, Vaida F, Otwombe K, Cotton MF, et al
    Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa.
    AIDS. 2023;37:523-533.
    PubMed     Abstract available

  290. PATTEN GE, Euvrard J, Anderegg N, Boulle A, et al
    Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model.
    AIDS. 2023;37:513-522.
    PubMed     Abstract available

  291. CLUVER LD, Zhou S, Orkin M, Rudgard W, et al
    Impacts of intimate partner violence and sexual abuse on antiretroviral adherence among adolescents living with HIV in South Africa.
    AIDS. 2023;37:503-511.
    PubMed     Abstract available

  292. PORTWOOD C, Sexton H, Kumarendran M, Brandon Z, et al
    Perinatal outcomes associated with combination antiretroviral therapy compared with monotherapy.
    AIDS. 2023;37:489-501.
    PubMed     Abstract available

  293. SIEGEL DA, Thanh C, Wan E, Hoh R, et al
    Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.
    AIDS. 2023;37:477-488.
    PubMed     Abstract available

  294. MONDESERT E, Reynes J, Makinson A, Bargnoux AS, et al
    Cystatin C in addition to creatinine for better assessment of glomerular renal function decline in people with HIV receiving antiretroviral therapy.
    AIDS. 2023;37:447-454.
    PubMed     Abstract available

  295. ANDERSON K, Iyun V, Eley BS, Rabie H, et al
    Hospitalization among infants who initiate antiretroviral therapy before 3 months of age.
    AIDS. 2023;37:435-445.
    PubMed     Abstract available

  296. NOVITSKY V, Steingrimsson J, Howison M, Dunn CW, et al
    Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic.
    AIDS. 2023;37:389-399.
    PubMed     Abstract available

  297. CASTILLO-ROZAS G, Lopez MN, Soto-Rifo R, Vidal R, et al
    Enteropathy and gut dysbiosis as obstacles to achieve immune recovery in undetectable people with HIV: a clinical view of evidence, successes, and projections.
    AIDS. 2023;37:367-378.
    PubMed     Abstract available

    February 2023
  298. MITAL S, Kelly D, Hughes C, Nosyk B, et al
    Estimated cost-effectiveness of point-of-care testing in community pharmacies versus self-testing and standard laboratory testing for HIV.
    AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003526.
    PubMed     Abstract available

  299. MCCLUSKEY SM, Govender K, Adamson J, Gandhi M, et al
    Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure.
    AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003520.
    PubMed     Abstract available

  300. DE CASTRO N, Chazallon C, Brites C, Messou E, et al
    Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high-TB burden countries.
    AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003521.
    PubMed     Abstract available

  301. DAVIES CR, Vaida F, Otwombe K, Cotton MF, et al
    Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children: a longitudinal study.
    AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003525.
    PubMed     Abstract available

  302. CHEUNG PK, Lapointe HR, Sang Y, Ennis S, et al
    SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART.
    AIDS. 2023 Feb 14. doi: 10.1097/QAD.0000000000003519.
    PubMed     Abstract available

  303. GABERT R, Lama JR, Valdez R, Dasgupta S, et al
    Acute retroviral syndrome is associated with lower CD4 nadir and delayed viral suppression, which are blunted by immediate ART initiation.
    AIDS. 2023 Feb 9. doi: 10.1097/QAD.0000000000003511.
    PubMed     Abstract available

  304. SVENSSON AKUSJARVI S, Krishnan S, Ambikan AT, Mikaeloff F, et al
    Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment.
    AIDS. 2023 Feb 9. doi: 10.1097/QAD.0000000000003512.
    PubMed     Abstract available

  305. CASADO JL, Vizcarra P, Martin-Colmenarejo S, Del Pino J, et al
    Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003504.
    PubMed     Abstract available

  306. CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al
    Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508.
    PubMed     Abstract available

  307. ALFIE LG, Longueira YS, Pippo M, Cruces L, et al
    Increased risk of false positive HIV ELISA results after COVID-19.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003507.
    PubMed     Abstract available

  308. SLOGROVE AL, Davies MA, Phelanyane F, De Beer S, et al
    Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003506.
    PubMed     Abstract available

  309. ZHU W, Huang YA, Song R, Wiener J, et al
    An estimate of excess deaths among people with HIV during the COVID-19 pandemic in the United States, 2020.
    AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003503.
    PubMed     Abstract available

  310. HUANG Y, Liao Z, Dang P, Queen S, et al
    Longitudinal characterization of circulating extracellular vesicles and small RNA during simian immunodeficiency virus infection and antiretroviral therapy.
    AIDS. 2023 Feb 6. doi: 10.1097/QAD.0000000000003487.
    PubMed     Abstract available

  311. ZEWDIE K, Pickles M, Floyd S, Fidler S, et al
    Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection.
    AIDS. 2023 Feb 3. doi: 10.1097/QAD.0000000000003463.
    PubMed     Abstract available

  312. ZINO L, Jacobs TG, Nieuwenstein T, Grintjes K, et al
    Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report.
    AIDS. 2023;37:363-365.

  313. ALIYU GG, Lawton JG, Mitchell AB, Abimiku AG, et al
    Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.
    AIDS. 2023;37:333-339.
    PubMed     Abstract available

  314. HANTTU AM, Pekkala S, Satokari R, Hartikainen AK, et al
    Gut microbiota alterations after switching from a protease inhibitor or efavirenz to raltegravir in a randomized, controlled study.
    AIDS. 2023;37:323-332.
    PubMed     Abstract available

  315. SOOKAROMDEE P, Wiwanitkit V
    Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV.
    AIDS. 2023;37:365-366.

  316. MASENGA SK, Romanelli A, Kooij KW
    Plasma osteopontin in persons with HIV and the risk for cardiovascular disease.
    AIDS. 2023;37:355-357.

  317. O'SHEA JG, Neblett Fanfair R, Dasgupta S, Tie Y, et al
    Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015-2020.
    AIDS. 2023;37:347-353.
    PubMed     Abstract available

  318. MARTIN C, Domingo C, Hainaut M, Delforge M, et al
    Seroconversion and persistence of neutralizing antibody response after yellow fever vaccination in patients with perinatally acquired HIV infection.
    AIDS. 2023;37:341-346.
    PubMed     Abstract available

  319. ROBINSON JA, Toribio M, Quinaglia T, Awadalla M, et al
    Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIV.
    AIDS. 2023;37:305-310.
    PubMed     Abstract available

  320. LANG R, Gill MJ, Coburn SB, Grossman J, et al
    The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017.
    AIDS. 2023;37:287-298.
    PubMed     Abstract available

  321. SORSTEDT E, Tetens MM, Nilsson S, Nowak P, et al
    Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies.
    AIDS. 2023;37:279-286.
    PubMed     Abstract available

  322. MOUCHATI C, Durieux JC, Zisis SN, McComsey GA, et al
    HIV and race are independently associated with endothelial dysfunction.
    AIDS. 2023;37:271-277.
    PubMed     Abstract available

  323. LANG R, Hogan B, Zhu J, McArthur K, et al
    The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum.
    AIDS. 2023;37:259-269.
    PubMed     Abstract available

  324. GARTNER MJ, Tumpach C, Dantanarayana A, Stern J, et al
    Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV.
    AIDS. 2023;37:247-257.
    PubMed     Abstract available

  325. REMIEN RH, Dacus JD, Farley JE, Hughes JP, et al
    HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States.
    AIDS. 2023;37:217-231.
    PubMed     Abstract available

  326. PRENDERGAST AJ, Evans C
    Children who are HIV-exposed and uninfected: evidence for action.
    AIDS. 2023;37:205-215.
    PubMed     Abstract available

  327. RAO A, Lesko C, Mhlophe H, Rucinski K, et al
    Longitudinal patterns of initiation, persistence, and cycling on PrEP among female sex workers and adolescent girls and young women in South Africa, 2016-2021.
    AIDS. 2023 Feb 1. doi: 10.1097/QAD.0000000000003500.
    PubMed     Abstract available

  328. RUDERMAN SA, Nance RM, Drumright LN, Whitney BM, et al
    Development of frail RISC-HIV: a risk score for predicting frailty risk in the short-term for care of people with HIV.
    AIDS. 2023 Feb 1. doi: 10.1097/QAD.0000000000003501.
    PubMed     Abstract available

    January 2023
  329. NEARY J, Fish CS, Cassidy NA, Wamalwa D, et al
    Predictors of intact HIV DNA levels among children in Kenya.
    AIDS. 2023 Jan 31. doi: 10.1097/QAD.0000000000003499.
    PubMed     Abstract available

  330. BOLZENIUS J, Sacdalan C, Ndhlovu LC, Sailasuta N, et al
    Brain volumetrics differ by fiebig stage in acute HIV infection.
    AIDS. 2023 Jan 30. doi: 10.1097/QAD.0000000000003496.
    PubMed     Abstract available

  331. FONNER VA, Ridgeway K, Van Der Straten A, Lorenzetti L, et al
    Safety and efficacy of long-acting injectable cabotegravir as pre-exposure prophylaxis to prevent HIV acquisition: a systematic review and meta-analysis.
    AIDS. 2023 Jan 26. doi: 10.1097/QAD.0000000000003494.
    PubMed     Abstract available

  332. MAZZITELLI M, Trunfio M, Milinkovic A, Castelli E, et al
    Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people living with HIV.
    AIDS. 2023 Jan 25. doi: 10.1097/QAD.0000000000003493.
    PubMed     Abstract available

  333. ARRIGONI FIF, Spyer M, Hunter P, Alber D, et al
    Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study.
    AIDS. 2023 Jan 23. doi: 10.1097/QAD.0000000000003488.
    PubMed     Abstract available

  334. MAMIDI RS, Ayubcha C, Rigney G, Kirschner J, et al
    A prospective 18F-FDG PET/CT study of the neurometabolic effects in cocaine use and HIV infection.
    AIDS. 2023 Jan 20. doi: 10.1097/QAD.0000000000003485.
    PubMed     Abstract available

  335. YANG X, Zhang J, Chen S, Weissman S, et al
    The impact of COVID-19 pandemic on the dynamic HIV care engagement among people with HIV: real-world evidence.
    AIDS. 2023 Jan 20. doi: 10.1097/QAD.0000000000003491.
    PubMed     Abstract available

  336. BLONDET F, Kraege V, Matthias C, Fernandez JD, et al
    Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study.
    AIDS. 2023 Jan 19. doi: 10.1097/QAD.0000000000003486.
    PubMed     Abstract available

  337. PINTYE J, Odoyo J, Nyerere B, Achieng P, et al
    Nurse-facilitated PrEP delivery for adolescent girls and young women seeking contraception at retail pharmacies in Kisumu, Kenya.
    AIDS. 2023 Jan 18. doi: 10.1097/QAD.0000000000003447.
    PubMed     Abstract available

  338. NEUFELD B, Cholette F, Sandstrom P, Musyoki H, et al
    HIV acquisition prior to entry into formal sex work: inference from next-generation viral sequencing.
    AIDS. 2023 Jan 17. doi: 10.1097/QAD.0000000000003484.
    PubMed     Abstract available

  339. BYERS BW, Drak D, Shamu T, Chimbetete C, et al
    Assessing Renal Impairment in Treatment-Naive Adolescents Living with HIV Commencing Antiretroviral Therapy In Zimbabwe.
    AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003482.
    PubMed     Abstract available

  340. MAUAS R, Urena A, Cecchini D, Strada ML, et al
    Adverse events and SARS-CoV-2 antibody responses after immunization with sputnik V, ChAdOx1-S and BBIBP-CorV vaccines in people with HIV.
    AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003483.
    PubMed     Abstract available

  341. BOWMAN C, Ambrose A, Kanitkar T, Flores K, et al
    Real world use of dolutegravir two drug regimens.
    AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003480.
    PubMed     Abstract available

  342. VAN OMMEN CE, Hsieh AYY, Albert AY, Kimmel ER, et al
    Lower anti-mullerian hormone levels are associated with HIV in reproductive age women and shorter leukocyte telomere length among late reproductive age women.
    AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003481.
    PubMed     Abstract available

  343. GARBER DA, Guenthner P, Zhao C, Mitchell J, et al
    Broadly neutralizing antibody-mediated protection against SHIV infection among macaques with vaginal sexually transmitted infections.
    AIDS. 2023 Jan 9. doi: 10.1097/QAD.0000000000003472.
    PubMed     Abstract available

  344. RACCAGNI AR, Mileto D, Galli L, Bruzzesi E, et al
    HIV viral load monitoring during monkeypox virus infection among PLWH.
    AIDS. 2023 Jan 9. doi: 10.1097/QAD.0000000000003479.
    PubMed     Abstract available

  345. ZHOU S, Qi K, Nugent BM, Bersoff-Matcha SJ, et al
    Participation of HIV-1 infected treatment-naive females in clinical trials and sex differences in efficacy and safety outcomes.
    AIDS. 2023 Jan 9. doi: 10.1097/QAD.0000000000003478.
    PubMed     Abstract available

  346. RUKUNI R, Victoria S, Rehman AM, Mukwasi-Kahari C, et al
    Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe.
    AIDS. 2023 Jan 9. doi: 10.1097/QAD.0000000000003477.
    PubMed     Abstract available

  347. COLTART H, El Bouzidi K, Mulka L, Connor S, et al
    Marked clinical and radiological improvement following pembrolizumab therapy for HIV-associated PML-IRIS.
    AIDS. 2023;37:199-200.

    Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots.
    AIDS. 2023;37:197-198.

  349. BENGTSON AM, Pellowski J, McGarvey S, McGinty R, et al
    In-utero HIV exposure and cardiometabolic health among children 5-8 years: findings from a prospective birth cohort in South Africa.
    AIDS. 2023;37:173-182.
    PubMed     Abstract available

  350. MCMAHON WC, Kwatra G, Izu A, Koen AL, et al
    T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa.
    AIDS. 2023;37:105-112.
    PubMed     Abstract available

  351. MOCROFT A, Geressu A, Beguelin C, Llibre JM, et al
    The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
    AIDS. 2023;37:91-103.
    PubMed     Abstract available

  352. WIJSTMA E, Vanhamel J, Deblonde J, Nostlinger C, et al
    An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis.
    AIDS. 2023;37:1-17.
    PubMed     Abstract available

  353. COSTINIUK CT, Singer J, Lee T, Langlois MA, et al
    COVID-19 vaccine immunogenicity in people with HIV.
    AIDS. 2023;37:F1-F10.
    PubMed     Abstract available

  354. KUHN S, Klinker H, Umland T, Baier M, et al
    Viral break through during dolutegravir-based antiretroviral therapy after excessive consumption of fruit juices.
    AIDS. 2023;37:200-203.

    December 2022
  355. RAJASURIAR R, Li CM, Ross JL, Jiamsakul A, et al
    Factors associated with reduced function and quality of life among adult plwh with depression and substance use in the asia-pacific region.
    AIDS. 2022 Dec 30. doi: 10.1097/QAD.0000000000003474.
    PubMed     Abstract available

  356. MUGO C, Kohler P, Kumar M, Badia J, et al
    Effect of HIV stigma on depressive symptoms, treatment adherence, and viral suppression among youth with HIV.
    AIDS. 2022 Dec 30. doi: 10.1097/QAD.0000000000003473.
    PubMed     Abstract available

  357. SADINSKI LM, Westreich D, Edmonds A, Breger TL, et al
    Hypertension and one-year risk of all-cause mortality among women with treated HIV in the United States.
    AIDS. 2022 Dec 26. doi: 10.1097/QAD.0000000000003461.
    PubMed     Abstract available

  358. CROTHERS K, Nance RM, Whitney BM, Harding BN, et al
    Copd And The Risk For Myocardial Infarction By Type In People With Hiv.
    AIDS. 2022 Dec 26. doi: 10.1097/QAD.0000000000003465.
    PubMed     Abstract available

  359. HENDERSON ER, Haberlen SA, Coulter RWS, Weinstein AM, et al
    The role of social support on cognitive function among midlife and older adult men who have sex with men.
    AIDS. 2022 Dec 26. doi: 10.1097/QAD.0000000000003464.
    PubMed     Abstract available

  360. MAZAHERI T, Buchanan D, Hung R, Campbell L, et al
    Creatinine and cystatin C-based eGFR estimate of kidney function in black people with HIV on antiretroviral therapy.
    AIDS. 2022 Dec 26. doi: 10.1097/QAD.0000000000003466.
    PubMed     Abstract available

  361. HORNER MJ, Hazra R, Barnholtz-Sloan JS, Shiels MS, et al
    Cancer risk among HIV-exposed uninfected children in the United States.
    AIDS. 2022 Dec 23. doi: 10.1097/QAD.0000000000003458.
    PubMed     Abstract available

  362. LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al
    Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART.
    AIDS. 2022 Dec 23. doi: 10.1097/QAD.0000000000003469.
    PubMed     Abstract available

  363. SUKUMARAN L, Kunisaki KM, Bakewell N, Winston A, et al
    Association between inflammatory biomarker profiles and cardiovascular risk in individuals with and without HIV.
    AIDS. 2022 Dec 15. doi: 10.1097/QAD.0000000000003462.
    PubMed     Abstract available

  364. PERNA A, Carleo MA, Mascolo S, Guida A, et al
    Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model.
    AIDS. 2022 Dec 13. doi: 10.1097/QAD.0000000000003455.
    PubMed     Abstract available

  365. SCHRUBBE LA, Stockl H, Hatcher AM, Marston M, et al
    Prevalence and risk factors of unsuppressed viral load among pregnant and breastfeeding women in sub-Saharan Africa: analysis from population-based surveys.
    AIDS. 2022 Dec 12. doi: 10.1097/QAD.0000000000003459.
    PubMed     Abstract available

  366. ONG JJ, Booton RD, Tucker JD, Tang W, et al
    Economic evaluation of improving HIV self-testing among men who have sex with men in China using a crowdsourced intervention: a cost-effectiveness analysis.
    AIDS. 2022 Dec 12. doi: 10.1097/QAD.0000000000003457.
    PubMed     Abstract available

  367. MURRAY DD, Grund B, MacPherson C, Ekenberg C, et al
    Association between TET2 genetic variation and viral load in people living with HIV.
    AIDS. 2022 Dec 8. doi: 10.1097/QAD.0000000000003427.
    PubMed     Abstract available

  368. ANTEL K, Oosthuizen J, Brown K, Malherbe F, et al
    Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis- and HIV-endemic region.
    AIDS. 2022 Dec 7. doi: 10.1097/QAD.0000000000003456.
    PubMed     Abstract available

  369. NIKOLOSKI Z, King EJ, Mosialos E
    Human immunodeficiency virus in the Russian Federation: mortality, prevalence, risk factors, and current understanding of sexual transmission.
    AIDS. 2022 Dec 7. doi: 10.1097/QAD.0000000000003441.
    PubMed     Abstract available

  370. LIPPMAN SA, Dekadt J, Ratlhagana MJ, Agnew E, et al
    Impact of SMS and Peer Navigation on linkage to care and ART initiation in South Africa: secondary results from a three-arm cluster randomized controlled trial.
    AIDS. 2022 Dec 6. doi: 10.1097/QAD.0000000000003453.
    PubMed     Abstract available

  371. JAO J, Kacanek D, Broadwell C, Jacobson DL, et al
    Gestational weight gain in persons living with HIV in the United States: results from the PHACS SMARTT study.
    AIDS. 2022 Dec 5. doi: 10.1097/QAD.0000000000003454.
    PubMed     Abstract available

  372. Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks: Erratum.
    AIDS. 2022;36:2235.

  373. BARCHI V, Rindi LV, Iannazzo R, Massa B, et al
    Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient.
    AIDS. 2022;36:2231-2233.

  374. MITINI-NKHOMA SC, Mzinza DT, Chimbayo ET, Chirambo AP, et al
    Latent tuberculosis infection among adults attending HIV services at an urban tertiary hospital in Malawi.
    AIDS. 2022;36:2229-2231.

  375. OKEGBE T, Mason J, Schueller J, Muraleetharan O, et al
    Opportunities to strengthen integration of family planning into HIV platforms to achieve the UNAIDS 2030 fast-track targets.
    AIDS. 2022;36:2221-2224.

    Evolution of weight and BMI during the course of HIV infection: historical perspective and challenges for clinical research.
    AIDS. 2022;36:2217-2219.

  377. COSTINIUK CT, Ahmad A
    Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre.
    AIDS. 2022;36:2215-2216.

  378. MASENGA SK, Cote HCF, Hunt PW
    Subclinical cardiac disease in children with perinatally acquired HIV is associated with inflammation.
    AIDS. 2022;36:2213-2214.

  379. DEL AMO J, Polo R, Moreno S, Martinez E, et al
    Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection.
    AIDS. 2022;36:2171-2179.
    PubMed     Abstract available

  380. BEER L, Tie Y, Dasgupta S, McManus T, et al
    Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV - United States, May 2015-June 2020.
    AIDS. 2022;36:2161-2169.
    PubMed     Abstract available

  381. LUGO REYES SO, Solorzano Suarez A, Scheffler Mendoza SC, Xochihua Diaz L, et al
    Activating de novo monoallelic variants causing inborn errors of immunity in two unrelated children born of HIV-seroconcordant couples.
    AIDS. 2022;36:2121-2128.
    PubMed     Abstract available

  382. MARTINEZ SS, Stebliankin V, Hernandez J, Martin H, et al
    Multiomic analysis reveals microbiome-related relationships between cocaine use and metabolites.
    AIDS. 2022;36:2089-2099.
    PubMed     Abstract available

    November 2022
  383. SHAKIL SS, Temu TM, Kityo C, Nazzinda R, et al
    Sex modulates the association between inflammation and coronary atherosclerosis among older Ugandan adults with and without HIV.
    AIDS. 2022 Nov 30. doi: 10.1097/QAD.0000000000003451.
    PubMed     Abstract available

  384. CHASTAIN DB, Motoa G, Ortiz-Martinez Y, Gharamti AE, et al
    Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: A retrospective cohort.
    AIDS. 2022 Nov 30. doi: 10.1097/QAD.0000000000003449.
    PubMed     Abstract available

  385. HILL LA, Abulhosn KK, Yin JF, Bamford LP, et al
    Single center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine.
    AIDS. 2022 Nov 29. doi: 10.1097/QAD.0000000000003446.
    PubMed     Abstract available

  386. YUAN Z, Giron LB, Hart C, Gyampoh A, et al
    Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice.
    AIDS. 2022 Nov 28. doi: 10.1097/QAD.0000000000003443.
    PubMed     Abstract available

  387. JAGI JL, Thomas C, Gudi SK, Undela K, et al
    Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2022 Nov 23. doi: 10.1097/QAD.0000000000003436.
    PubMed     Abstract available

  388. CHACHAGE M, Parikh AP, Mahenge A, Bahemana E, et al
    High-risk human papillomavirus (HPV) genotype distribution among women living with and at risk for HIV in the African cohort study.
    AIDS. 2022 Nov 21. pii: 00002030-990000000-00153.
    PubMed     Abstract available

  389. DOUGLAS PS, Mccallum S, Lu MT, Umbleja T, et al
    Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
    AIDS. 2022 Nov 18. doi: 10.1097/QAD.0000000000003418.
    PubMed     Abstract available

  390. SINGH KP, Pallett LJ, Singh H, Chen A, et al
    Pro-fibrogenic role of alarmin HMGB1 in HIV-HBV co-infection.
    AIDS. 2022 Nov 17. pii: 00002030-990000000-00152.
    PubMed     Abstract available

  391. MAZZITELLI M, Sasset L, Leoni D, Barbaro F, et al
    HIV testing and linkage to care: are we missing some opportunities?
    AIDS. 2022;36:2085-2087.

  392. CONNER MG, Vwalika B, Freeman BL, Sebastiao YV, et al
    Effect of weekly 17-hydroxyprogesterone caproate on small for gestational age among pregnant women with HIV in Zambia.
    AIDS. 2022;36:2079-2081.
    PubMed     Abstract available

  393. COLLINI P, Winslow DL
    Addressing the burden of HIV-associated chronic lung disease in West Africa.
    AIDS. 2022;36:2075-2076.

  394. ZACCARELLI M, Musiime V, Quinones-Mateu ME
    Monitoring antiretroviral therapy in low and middle-income countries: current status and future considerations.
    AIDS. 2022;36:2071-2073.

  395. RATHORE U
    Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy.
    AIDS. 2022;36:2063-2064.

  396. VAN ZYL G, Jennings L, Kellermann T, Nkantsu Z, et al
    Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.
    AIDS. 2022;36:2057-2062.
    PubMed     Abstract available

  397. TRICKEY A, Walker JG, Bivegete S, Semchuk N, et al
    Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among MSM.
    AIDS. 2022;36:2025-2034.
    PubMed     Abstract available

  398. MILNE RS, Beck IA, Levine M, So I, et al
    Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy.
    AIDS. 2022;36:1949-1958.
    PubMed     Abstract available

  399. HOENIGL M, Smith LR, Egger M, Mittal ML, et al
    Good2Go: perceptions and impact of a community-based comprehensive sexual health screening program in San Diego, California.
    AIDS. 2022;36:2083-2085.

  400. WOOLLEY I, Boix V, Polizzotto MN
    Human herpes virus 8-related illness: still with us.
    AIDS. 2022;36:2067-2069.

  401. ROSSOUW TM, Makhalanyane TP
    Dysbiosis and immune dysregulation: distilling the evidence.
    AIDS. 2022;36:2065-2066.

  402. WAALEWIJN H, Stol K, van der Knaap L, Fraaij PLA, et al
    Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara Africa.
    AIDS. 2022;36:2077-2079.
    PubMed     Abstract available

  403. VENTER F, Sokhela S, Calmy A, Siedner MJ, et al
    Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1900-1901.

  404. TARAMASSO L, Di Biagio A, Guaraldi G
    Response to: weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1899-1900.

  405. AHLUWALIA AK, Inzaule S, Baggaley RC, Vitoria M, et al
    Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.
    AIDS. 2022;36:1897-1898.

  406. CARRARO A, Belvisi V, Garattini S, Cacace S, et al
    A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents.
    AIDS. 2022;36:1895-1896.

  407. KOWALSKA JD, Rukhadze N, Sojak L, Bociaga-Jasik M, et al
    Preliminary report on the provision of HIV care to war refugees with HIV who are migrating from Ukraine: data from the ECEE Network Group.
    AIDS. 2022;36:1887-1890.
    PubMed     Abstract available

  408. XIA Q, Edelstein ZR, Blumenthal JS
    Improving HIV preexposure prophylaxis implementation within healthcare settings.
    AIDS. 2022;36:1883-1885.

  409. DUARTE FC, Moura LM, Laranjinha J
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022;36:1881-1882.

  410. LAEREMANS T, D'haese S, Aernout J, Barbe K, et al
    Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH.
    AIDS. 2022;36:1761-1768.
    PubMed     Abstract available

  411. LUMU I, Musaazi J, Castelnuovo B
    Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting.
    AIDS. 2022;36:1791-1800.
    PubMed     Abstract available

    October 2022
  412. PRINS HAB, Rokx C, Verbon A, van Sighem A, et al
    HIV transmission among acutely infected participants of a Dutch cohort study 2015-2021 is not associated with large, clustered outbreaks.
    AIDS. 2022 Oct 28. pii: 00002030-990000000-00134.
    PubMed     Abstract available

  413. CUMMINGS MJ, Bakamutumaho B, Price A, Owor N, et al
    HIV infection drives pro-inflammatory immunothrombotic pathway activation and organ dysfunction among adults with sepsis in Uganda: a prospective cohort study.
    AIDS. 2022 Oct 24. pii: 00002030-990000000-00130.
    PubMed     Abstract available

  414. ZHOU CY, Wang RN, He WT, Luo DR, et al
    Functional analysis of the antigen binding sites on the MTB/HIV-1 Peptide Bispecific T Cell Receptor Complementarity Determining Region 3alpha.
    AIDS. 2022 Oct 20. pii: 00002030-990000000-00128.
    PubMed     Abstract available

  415. CHAMBERS C, Samji H, Cooper CL, Costiniuk CT, et al
    COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV.
    AIDS. 2022 Oct 19. pii: 00002030-990000000-00126.
    PubMed     Abstract available

  416. LAWTON J, Lavoie MC, Bashorun A, Dalhatu I, et al
    Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey.
    AIDS. 2022 Oct 14. pii: 00002030-990000000-00125.
    PubMed     Abstract available

  417. ALLAVENA C, Blain H, Abulizi X, Slama L, et al
    Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older.
    AIDS. 2022 Oct 12. pii: 00002030-990000000-00123.
    PubMed     Abstract available

  418. TUSCH ES, Ryom L, Fursa O, Peters L, et al
    Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in persons living with HIV.
    AIDS. 2022 Oct 12. pii: 00002030-990000000-00124.
    PubMed     Abstract available

  419. DICKSON S, Gabriel N, Hernandez I
    Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide.
    AIDS. 2022 Oct 7. pii: 00002030-990000000-00122.
    PubMed     Abstract available

  420. MEI Z, Yin MT, Sharma A, Wang Z, et al
    Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection.
    AIDS. 2022 Oct 5. pii: 00002030-990000000-00121.
    PubMed     Abstract available

  421. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors' reply.
    AIDS. 2022;36:1747-1748.

    Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV.
    AIDS. 2022;36:1746-1747.

  423. JONAS KJ, Parczewski M, van de Vijver D
    The war refugees from Ukraine: an HIV epidemic is fleeing as well.
    AIDS. 2022;36:1745-1746.

  424. LANGLIE J, Mittal R, Bencie NB, Sharma U, et al
    Unraveling the mechanisms of HIV-induced hearing loss.
    AIDS. 2022;36:1737-1740.

    The right balance between weight gain and insulin sensitivity with integrase inhibitors.
    AIDS. 2022;36:1735-1736.

  426. MILIC J, Guaraldi G
    Hormone therapy in postmenopausal women living with HIV: a view towards prevention of multiple metabolic conditions and improvement of quality of life.
    AIDS. 2022;36:1731-1733.

    September 2022
  427. HAGENIMANA M, Kodan AE, George N, Businge L, et al
    Cancer in patients with and without HIV infection in the national cancer registry of Rwanda.
    AIDS. 2022 Sep 28. pii: 00002030-990000000-00120.
    PubMed     Abstract available

  428. SATISH S, Bravo L, McAllister A, Teitelman A, et al
    Provision of HIV pre-exposure prophylaxis to female patients seeking family planning services in the United States.
    AIDS. 2022 Sep 22. pii: 00002030-990000000-00119.
    PubMed     Abstract available

  429. LUBEGA J, Kim TO, Airewele G, Grimes A, et al
    Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on anti-retrovirus therapy.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00116.
    PubMed     Abstract available

  430. JOVANOVIC L, Siljic M, Cirkovic V, Salemovic D, et al
    HIV-1 subtype B spread through cross-border clusters in the balkans: a molecular analysis in view of incidence trends.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00115.
    PubMed     Abstract available

  431. RASMUSSEN LD, Cowan S, Gerstoft J, Kronborg G, et al
    Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00118.
    PubMed     Abstract available

  432. AYTON S, Schwitters A, Mantell JE, Nuwagaba-Biribonwoha H, et al
    Male partner age, viral load, and HIV infection in adolescent girls and young women: Evidence from eight sub-Saharan African countries.
    AIDS. 2022 Sep 20. pii: 00002030-990000000-00117.
    PubMed     Abstract available

  433. YOUNGPAIROJ AS, Vanderford TH, Reed MS, Granade TC, et al
    A monoclonal antibody for the detection of the antiretroviral drug emtricitabine.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00092.
    PubMed     Abstract available

  434. MYER L, Odayar J, Malaba TR, Allerton J, et al
    Improved virologic outcomes in postpartum women living with HIV referred to differentiated models of care: a randomised controlled trial.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00113.
    PubMed     Abstract available

  435. MORAN CA, Oliver NT, Szabo B, Collins LF, et al
    The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age.
    AIDS. 2022 Sep 16. pii: 00002030-990000000-00112.
    PubMed     Abstract available

  436. KENG LD, Winston A, Sabin CA
    The global burden of cognitive impairment in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00110.
    PubMed     Abstract available

  437. SEN S, An H, Oakes J, Eron J, et al
    Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00109.
    PubMed     Abstract available

  438. STONE J, Fraser H, Walker JG, Mafirakureva N, et al
    Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya.
    AIDS. 2022 Sep 15. pii: 00002030-990000000-00111.
    PubMed     Abstract available

  439. KIDMAN R, Breton E, Behrman J, Kohler HP, et al
    A prospective study on adverse childhood experiences and HIV-related risk among adolescents in Malawi.
    AIDS. 2022 Sep 12. pii: 00002030-990000000-00108.
    PubMed     Abstract available

  440. PHIPPS W, Adams SV, Mooka P, Kafeero J, et al
    A prospective study of HIV-associated and hiv-negative kaposi sarcoma in Uganda: identifying factors associated with poor outcomes.
    AIDS. 2022 Sep 5. pii: 00002030-990000000-00107.
    PubMed     Abstract available

  441. KOBBE R, Schulze-Sturm U, Kurnaz P, Rau C, et al
    Vertical anti-SARS-CoV-2 monoclonal antibody transfer from mothers to HIV-exposed and unexposed infants.
    AIDS. 2022;36:1613-1615.

  442. LONGHITANO A, Woolley I, Upjohn L, Korman T, et al
    New diagnosis of HIV with Cryptococcus neoformans infection presenting as a pleural syndrome.
    AIDS. 2022;36:1611-1613.

  443. SATTA S, Hugo C, Sharma M, Rezek V, et al
    Mitoquinone mesylate attenuates brain inflammation in humanized mouse model of chronic HIV infection.
    AIDS. 2022;36:1609-1611.

  444. LONDERO A, Fusi M, Cinausero M, Tascini C, et al
    Effects of the androgen receptor inhibitor enzalutamide on the pharmacokinetics of dolutegravir and tenofovir: a case report.
    AIDS. 2022;36:1603-1605.
    PubMed     Abstract available

    HIV accelerates clonal hematopoiesis and cardiovascular aging.
    AIDS. 2022;36:1599-1601.

  446. CONWAY B, Brenner BG
    Can simplified antiretroviral drug combination therapies resist resistance?
    AIDS. 2022;36:1597-1598.

  447. TITANJI BK, Wang Z, Chen J, Hui Q, et al
    Soluble CD14-associated DNA methylation sites predict mortality among men with HIV infection.
    AIDS. 2022;36:1563-1571.
    PubMed     Abstract available

  448. ETZKORN LH, Liu F, Urbanek JK, Heravi AS, et al
    Patterns of objectively measured physical activity differ between men living with and without HIV.
    AIDS. 2022;36:1553-1562.
    PubMed     Abstract available

  449. SAVINELLI S, Wrigley Kelly NE, Feeney ER, O'Shea DB, et al
    Obesity in HIV infection: host-pathogen interaction.
    AIDS. 2022;36:1477-1491.
    PubMed     Abstract available

  450. LUBEGA J, Grimes A, Airewele G, Bulsara S, et al
    Risk factors and prognostic significance of anemia in children with hiv infection on anti-retroviral therap.
    AIDS. 2022 Sep 1. pii: 00002030-990000000-00106.
    PubMed     Abstract available

    August 2022
  451. LUCAS J, Lin LY, Paul N, Laumond G, et al
    Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00101.
    PubMed     Abstract available

  452. JASCHINSKI N, Greenberg L, Neesgaard B, Miro JM, et al
    Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00102.
    PubMed     Abstract available

  453. MAJONGA ED, Yindom LM, Hameiri-Bowen D, Mayini J, et al
    Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00100.
    PubMed     Abstract available

  454. AJAYKUMAR A, Caloren LC, Povshedna T, Hsieh AYY, et al
    Dolutegravir-containing HIV therapy reversibly alters mitochondrial health and morphology in cultured human fibroblasts and PBMC.
    AIDS. 2022 Aug 24. pii: 00002030-990000000-00104.
    PubMed     Abstract available

  455. THINDWA D, Mwalukomo TS, Msefula J, Jambo KC, et al
    Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.
    AIDS. 2022 Aug 22. pii: 00002030-990000000-00094.
    PubMed     Abstract available

  456. WHITE HA, Baggaley RF, Okhai H, Patel H, et al
    The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent TB infection testing in HIV: cohort study results.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00096.
    PubMed     Abstract available

  457. FINK DL, Oladele DA, Slack AJ, Odubela O, et al
    A multicentre observational study of HIV, TB and risk of chronic lung disease in urban west Africa.
    AIDS. 2022 Aug 19. pii: 00002030-990000000-00093.
    PubMed     Abstract available

  458. THEERASUWIPAKORN N, Rungpradubvong V, Chattranukulchai P, Siwamogsatham S, et al
    Higher prevalence of QTc interval prolongation among virologically suppressed older people living with HIV.
    AIDS. 2022 Aug 16. pii: 00002030-990000000-00090.
    PubMed     Abstract available

  459. SMITH SA, Murray PM, Amancha PK, Ackerley CG, et al
    T cell activation and B cell interaction signatures in rectal tissues are associated with HIV replication in ex vivo model of infection.
    AIDS. 2022 Aug 16. pii: 00002030-990000000-00091.
    PubMed     Abstract available

  460. HERMANS LE, Ter Heine R, Schuurman R, Tempelman HA, et al
    A randomised study of intensified ART monitoring versus standard-of-care for prevention of drug resistance and ART switch: week 96 results of the ITREMA trial.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00083.
    PubMed     Abstract available

  461. LAKE JE, Wang R, Barrett BW, Bowman E, et al
    Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00081.
    PubMed     Abstract available

  462. DUARTE M, Ma Y, Noworolski SM, Korn N, et al
    Controlled Attenuation Parameter Accurately Detects Liver Steatosis in People Living with HIV.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00082.
    PubMed     Abstract available

  463. JAIN JP, Sheira LA, Frongillo EA, Neilands TB, et al
    Mechanisms linking gender-based violence to worse HIV treatment and care outcomes among women in the United States.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00080.
    PubMed     Abstract available

  464. SPIELER G, Westfall AO, Long DM, Cherrington A, et al
    Trends in diabetes incidence and associated risk factors among people living with HIV in the current treatment era, 2008-2018.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00084.
    PubMed     Abstract available

  465. NUNES MC, Jones S, Ditse Z, da Silva K, et al
    Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection.
    AIDS. 2022 Aug 11. pii: 00002030-990000000-00085.
    PubMed     Abstract available

  466. ALRUBAYYI A, Rowland-Jones S, Peppa D
    Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy.
    AIDS. 2022 Aug 8. pii: 00002030-990000000-00055.
    PubMed     Abstract available

  467. BARNETT SK, Armas-Kolostroubis L, Sension M, Riedel DJ, et al
    Cabotegravir-rilpivirine treatment initiation in a nonvirologically suppressed patient.
    AIDS. 2022;36:1475-1476.

  468. PHILLIPS AN, Sibanda E, Sikwese K, Bansi-Matharu L, et al
    Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa.
    AIDS. 2022;36:1473-1475.

  469. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Fatty liver disease in children living with HIV: a ghostly iceberg.
    AIDS. 2022;36:1471-1472.

  470. SEBASTIANI G, Sebastiani G
    Fatty liver in children with HIV: a clinical iceberg?
    AIDS. 2022;36:1469-1471.

  471. CHAMMARTIN F, Kusejko K, Pasin C, Trkola A, et al
    Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.
    AIDS. 2022;36:1465-1468.
    PubMed     Abstract available

  472. LURAIN K, Uldrick TS, Navarro JT
    Leveraging fine-needle aspiration to improve HIV-associated lymphoma diagnostic capacity in resource-limited settings.
    AIDS. 2022;36:1461-1463.

  473. STAPLETON JT, Bedimo RJ, Guaraldi G
    Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV.
    AIDS. 2022;36:1457-1459.

  474. SCHNEIDER JA, Bouris A
    Ryan White programming that primarily supports clinical care falls short when core people needs are not met: further evidence from the medical monitoring project.
    AIDS. 2022;36:1453-1456.

  475. WOOD BR, Stekler JD
    Baseline HIV genotype drug resistance testing: is it time for more or less?
    AIDS. 2022;36:1449-1451.

    July 2022
  476. FITCH KV, Mccallum SA, Erlandson KM, Overton ET, et al
    Diet in a global cohort of adults with HIV at Low to Moderate Traditional Cardiovascular Disease Risk.
    AIDS. 2022 Jul 27. pii: 00002030-990000000-00079.
    PubMed     Abstract available

  477. YAZDANI K, Salters K, Shen T, Dolguikh K, et al
    A twenty-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00076.
    PubMed     Abstract available

  478. MANN LM, Le Guillou A, Goodreau SM, Marcus JL, et al
    Correlations between community-level HIV preexposure prophylaxis coverage and individual-level sexual behaviors among US men who have sex with men.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00078.
    PubMed     Abstract available

  479. PALA AN, Kempf MC, Konkle-Parker D, Wilson TE, et al
    Intersectional stigmas are associated with lower viral suppression Rates and ART adherence among Women living with HIV.
    AIDS. 2022 Jul 26. pii: 00002030-990000000-00075.
    PubMed     Abstract available

  480. LESKO CR, Edwards JK, Hanna DB, Mayor AM, et al
    Longitudinal HIV care outcomes by gender identity in the United States.
    AIDS. 2022 Jul 21. pii: 00002030-990000000-00074.
    PubMed     Abstract available

  481. PELUSO MJ, Spinelli MA, Deveau TM, Forman CA, et al
    Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection.
    AIDS. 2022 Jul 19. pii: 00002030-990000000-00073.
    PubMed     Abstract available

  482. RAI MA, Shi V, Kennedy BD, Whitehead EJ, et al
    Effect of aging on immune cells in male HIV-infected and -uninfected healthy individuals.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00069.
    PubMed     Abstract available

  483. HANSEN ME, Mangusan R, Lurain K, Odeny T, et al
    Characteristics of patients admitted to the intensive care unit with Kaposi sarcoma herpesvirus-associated diseases.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00068.
    PubMed     Abstract available

  484. ROUSSET S, Zenou M, Saunier A, Varenne F, et al
    Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV: a national survey and literature review.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00072.
    PubMed     Abstract available

  485. FOTSO AS, Johnson C, Vautier A, Kouame KB, et al
    Routine programmatic data show a positive population-level impact of HIV self-testing: the case of Cote d'Ivoire and implications for implementation.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00071.
    PubMed     Abstract available

  486. BANNISTER WP, Mast TC, de Wit S, Gerstoft J, et al
    Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens.
    AIDS. 2022 Jul 18. pii: 00002030-990000000-00070.
    PubMed     Abstract available

  487. HUNT M, Mcniff MM, Vincent AE, Sabin C, et al
    Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00060.
    PubMed     Abstract available

  488. HAU TTT, Nishizawa M, Harada S, Phan MH, et al
    Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00066.
    PubMed     Abstract available

  489. GIRARDI E, Caro-Vega Y, Cozzi-Lepri A, Musaazi J, et al
    The contribution of late HIV diagnosis on the occurrence of HIV-associated tuberculosis: a 5-year estimate using real-world data.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00065.
    PubMed     Abstract available

  490. TENG AE, Kennedy KF, Parikh RV, Armstrong EJ, et al
    Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00058.
    PubMed     Abstract available

  491. WEISER B, Shi B, Kemal K, Burger H, et al
    Long-term antiretroviral therapy mitigates mortality and morbidity independent of HIV tropism: 18 years follow-up in a women's cohort.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00061.
    PubMed     Abstract available

  492. MUNGWIRA RG, Laurens MB, Nyangulu W, Divala TH, et al
    High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00064.
    PubMed     Abstract available

  493. ZHU W, Huang YA, Weiner J, Neblett-Fanfair R, et al
    Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00062.
    PubMed     Abstract available

  494. LI G, Park LS, Lodi S, Logan RW, et al
    Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00063.
    PubMed     Abstract available

  495. TINCATI C, Ficara M, Ferrari F, Augello M, et al
    Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00067.
    PubMed     Abstract available

  496. PANNEER N, Balaji AB, Crim SM, Bosh KA, et al
    Assessing concordance of HIV risk behaviors collected by different surveillance systems.
    AIDS. 2022 Jul 15. pii: 00002030-990000000-00059.
    PubMed     Abstract available

  497. NEARY J, Mugo C, Wagner A, Ogweno V, et al
    Caregiver fears and assumptions about child HIV status drive not testing children for HIV.
    AIDS. 2022;36:1323-1325.

  498. BOTTANELLI M, Messina E, Barbera M, Guffanti M, et al
    Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV.
    AIDS. 2022;36:1321-1323.

  499. GIANSERRA L, Dona MG, Giuliani E, Stingone C, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:1319-1320.

  500. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
    AIDS. 2022;36:1315-1317.
    PubMed     Abstract available

    Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection.
    AIDS. 2022;36:1311-1313.

  502. POLI G, Stapleton JT
    Sex matters... cytokines and disease progression in men and women receiving combination antiretroviral therapy.
    AIDS. 2022;36:1307-1309.

  503. CRUM NF, Ahmad A
    Immunity against measles in people with HIV: the need for more research and surveillance.
    AIDS. 2022;36:1305-1306.

  504. STOVER S, Milloy MJ, Grant C, Fairbairn N, et al
    Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs.
    AIDS. 2022;36:1233-1243.
    PubMed     Abstract available

  505. ZHAO B, Ding H, Song W, Kang M, et al
    Antiretroviral therapy initiation within 7 days and 8 days-30 days post-HIV diagnosis demonstrates similar benefits in resource-limited settings.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00056.
    PubMed     Abstract available

  506. ANTE-TESTARD PA, Hamidouche M, Apouey B, Baggaley R, et al
    Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries: a mediation analysis.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00057.
    PubMed     Abstract available

  507. HUIK K, Hill S, George J, Pau A, et al
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00033.
    PubMed     Abstract available

  508. MICHEL M, Labenz C, Wahl A, Anders M, et al
    Prevalence and risk factors of non-alcoholic steatohepatitis with significant fibrosis in people living with HIV.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00053.
    PubMed     Abstract available

  509. VAKILI S, Paneru B, Guerrier CM, Miller J, et al
    Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing ART.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00054.
    PubMed     Abstract available

  510. MICAN R, Grela AG, Cadinanos J, de Miguel R, et al
    Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data.
    AIDS. 2022 Jul 8. pii: 00002030-990000000-00052.
    PubMed     Abstract available

  511. SINGH A, Kumar A, Shankar S, Vashisht R, et al
    Triple trouble: syphilitic neuroretinitis preceding progressive outer retinal necrosis in a HIV-infected man.
    AIDS. 2022;36:1203-1204.

    How much do we need electronic clinical decision support systems to select patients to perform HIV tests in clinical settings?
    AIDS. 2022;36:1201-1202.

    Hypogonadism in HIV infection: time to fine-tune clinical monitoring of persons with HIV?
    AIDS. 2022;36:1197-1199.

  514. WOOD BR, Guthrie BL
    Recurrent bacterial sexually transmitted infections: lessons from an HIV preexposure prophylaxis trial.
    AIDS. 2022;36:1191-1193.

  515. LESKO CR, Mugavero MJ, Shen NM, Fojo AT, et al
    Exploring definitions of retention in care for people living with HIV in the United States in the modern treatment era.
    AIDS. 2022;36:1181-1189.
    PubMed     Abstract available

  516. IGNACIO RAB, Shapiro AE, Nance RM, Whitney BM, et al
    Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.
    AIDS. 2022;36:1095-1103.
    PubMed     Abstract available

  517. SMIT M, Jordans CCE, Reinhard JM, Bramer WM, et al
    Clinical decision support systems to guide healthcare providers on HIV testing.
    AIDS. 2022;36:1083-1093.
    PubMed     Abstract available

  518. COLEMAN H, Fox J, Chilton D
    The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case series.
    AIDS. 2022;36:1205-1206.

  519. HATCHER AM, Eakle R, Peltz A
    Partner violence as conversation opener for preexposure prophylaxis use among younger women.
    AIDS. 2022;36:1195-1196.

    June 2022
  520. FORD JS, Rouleau S, Voong S, Morgan B, et al
    Universal HIV screening in the emergency department: an interrupted time series analysis.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00040.
    PubMed     Abstract available

  521. CHAISSON LH, Semitala FC, Mwebe S, Katende J, et al
    Transaminitis prevalence among HIV-infected adults eligible for tuberculosis preventive therapy.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00051.
    PubMed     Abstract available

    A role for CD4 helper cells in HIV control and progression.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00045.
    PubMed     Abstract available

  523. PATEL R, Manion MM, Laidlaw E, Wakim P, et al
    Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00042.
    PubMed     Abstract available

  524. SPEARS CE, Taylor BS, Liu AY, Levy SM, et al
    Intersecting epidemics: the impact of COVID-19 on the HIV prevention and care continua in the United States.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00048.
    PubMed     Abstract available

  525. WANG S, Pasca S, Post WS, Langan S, et al
    Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00041.
    PubMed     Abstract available

  526. PATEL EU, Solomon SS, Mcfall AM, Prata Menezes N, et al
    Drug use stigma, antiretroviral therapy use, and HIV viral suppression in a community-based sample of people with HIV who inject drugs.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00050.
    PubMed     Abstract available

  527. WARD AR, Thomas AS, Stevenson EM, Huang SH, et al
    No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00046.
    PubMed     Abstract available

  528. YIN MT, Hoover DR, Shi Q, Tien PC, et al
    Hormone therapy and fracture rates among postmenopausal women: results from the Women's Interagency HIV Study.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00039.
    PubMed     Abstract available

  529. DONADEU L, Tiraboschi JM, Scevola S, Torija A, et al
    Long-lasting adaptive Immune memory specific to SARS-CoV-2 in convalescent COVID-19 Stable People living with HIV.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00049.
    PubMed     Abstract available

  530. FOWLER MG, Hanrahan C, Yende N, Stranix-Chibanda L, et al
    Neurodevelopmental Outcomes of HIV and Anti-retroviral Drug Perinatally Exposed Uninfected Children Aged 3-6 years.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00038.
    PubMed     Abstract available

  531. POURCHER V, Belin L, Soulie C, Rosenzwajg M, et al
    High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00043.
    PubMed     Abstract available

  532. DIETLER D, Farnham A, Lyatuu I, Fink G, et al
    Industrial mining and HIV risk: evidence from 39 mine openings across 16 countries in sub-Saharan Africa.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00047.
    PubMed     Abstract available

  533. CALLEJO A, Molina MDM, Dinares MC, Hernandez-Losa J, et al
    Exploratory study of an oral screening dysplasia program for HIV-infected men who have sex with men.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00044.
    PubMed     Abstract available

  534. SABERI P, Stoner MCD, Ming K, Lisha NE, et al
    The effect of an HIV pre-exposure prophylaxis (PrEP) panel management strategy to increase PrEP prescriptions.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00037.
    PubMed     Abstract available

  535. ELVSTAM O, Marrone G, Engstrom G, Nilsson PM, et al
    Associations between HIV viremia during antiretroviral therapy and cardiovascular disease.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00036.
    PubMed     Abstract available

  536. KAUPPINEN KJ, Aho I, Sutinen J
    Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain.
    AIDS. 2022 Jun 22. pii: 00002030-990000000-00035.
    PubMed     Abstract available

  537. MILIC J, Renzetti S, Ferrari D, Barbieri S, et al
    Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens.
    AIDS. 2022 Jun 21. pii: 00002030-990000000-00034.
    PubMed     Abstract available

  538. BUTTERFIELD TR, Hanna DB, Kaplan RC, Xue X, et al
    Elevated CD4+ T cell glucose metabolism in HIV+ women with diabetes mellitus.
    AIDS. 2022 Jun 21. pii: 00002030-990000000-00029.
    PubMed     Abstract available

  539. OKAL JO, Awiti JO, Matheka J, Oluoch-Madiang D, et al
    Unit costs of a community-based girl-centered HIV prevention program: a case study of Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe program.
    AIDS. 2022;36.
    PubMed     Abstract available

  540. PULERWITZ J, McClair T, Gottert A, Shabangu P, et al
    Effects of men's lifetime adverse events experience on violence, HIV risk, and wellbeing: insights from three countries.
    AIDS. 2022;36.
    PubMed     Abstract available

  541. GOTTERT A, Pulerwitz J, Heck CJ, Shabangu P, et al
    Inroads for HIV prevention among men: findings from mixed methods research in the context of the DREAMS partnership in Southern Africa.
    AIDS. 2022;36.
    PubMed     Abstract available

  542. MATHUR S, Mishra R, Mahapatra B, Heck CJ, et al
    Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women.
    AIDS. 2022;36.
    PubMed     Abstract available

  543. FLOYD S, Mulwa S, Magut F, Gourlay A, et al
    DREAMS impact on HIV status knowledge and sexual risk among cohorts of young women in Kenya and South Africa.
    AIDS. 2022;36.
    PubMed     Abstract available

  544. SAUL J, Cooney C, Hosseini PR, Beamon T, et al
    Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries.
    AIDS. 2022;36.
    PubMed     Abstract available

  545. MTHIYANE N, Baisley K, Chimbindi N, Zuma T, et al
    The association of exposure to DREAMS on sexually acquiring or transmitting HIV amongst adolescent girls and young women living in rural South Africa.
    AIDS. 2022;36.
    PubMed     Abstract available

  546. GOURLAY AJ, Birdthistle I, Mulwa S, Mthiyane NT, et al
    Awareness and uptake of the Determined, Resilient, Empowered, AIDS-free, Mentored and Safe HIV prevention package over time among population-based cohorts of young women in Kenya and South Africa.
    AIDS. 2022;36.
    PubMed     Abstract available

  547. PATEL P, Sato K, Bhandari N, Kanagasabai U, et al
    From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
    AIDS. 2022;36.
    PubMed     Abstract available

  548. SAUL J, Toiv N, Cooney C, Beamon T, et al
    The evolution of DREAMS: using data for continuous program improvement.
    AIDS. 2022;36.
    PubMed     Abstract available

  549. MULLICK S, Cowan FM
    Evaluating the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe programme, what's worked and what more needs to be done?
    AIDS. 2022;36.
    PubMed     Abstract available

  550. OLSSON O, Skogmar S, Tesfaye F, Mulleta D, et al
    Kynurenine/tryptophan ratio for detection of active tuberculosis in adults with HIV prior to antiretroviral therapy.
    AIDS. 2022 Jun 2. pii: 00002030-990000000-00026.
    PubMed     Abstract available

  551. HUNT M, Phillips R, Hardy Y, Owusu DO, et al
    Renal mitochondrial toxicity: effects of thymidine analogues and tenofovir disoproxil fumarate in African people with HIV.
    AIDS. 2022;36:1049-1051.
    PubMed     Abstract available

  552. POST FA, Sinxadi P
    Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are needed.
    AIDS. 2022;36:1047-1048.

  553. MURNANE PM, Gandhi M, Bacchetti P, Getahun M, et al
    Distinct forms of migration and mobility are differentially associated with HIV treatment adherence.
    AIDS. 2022;36:1021-1030.
    PubMed     Abstract available

  554. JIANG W, Ronen K, Osborn L, Drake AL, et al
    Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy.
    AIDS. 2022;36:1007-1019.
    PubMed     Abstract available

  555. KOUAMOU V, Inzaule S, Manasa J
    Weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2022;36:1053-1054.

  556. LE MOING V
    Real-time assessment of adherence to antiretroviral drugs: a moving target.
    AIDS. 2022;36:1045-1046.

    May 2022
  557. JUWONO S, Milloy MJ, Choi J, Fairbairn N, et al
    Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids.
    AIDS. 2022 May 24. pii: 00002030-990000000-00025.
    PubMed     Abstract available

  558. MUNOZ-MUELA E, Trujillo-Rodriguez M, Serna-Gallego A, Ruiz-Mateos E, et al
    Anti-CD4 autoantibodies in immunological non-responder people living with HIV: Cause of CD4+ T-cell depletion?
    AIDS. 2022 May 24. pii: 00002030-990000000-00019.
    PubMed     Abstract available

  559. VALINETZ ED, Matemo D, Gersh JK, Joudeh LL, et al
    Isoniazid preventive therapy and TB transcriptional signatures in people with HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00017.
    PubMed     Abstract available

  560. LOUW S, Gededzha MP, Mayne AL, Mayne ES, et al
    Thrombotic thrombocytopenic purpura (TTP) in Human immunodeficiency virus (HIV) infected patients: New twists on an old disease.
    AIDS. 2022 May 24. pii: 00002030-990000000-00023.
    PubMed     Abstract available

  561. INZAULE SC, Kroeze S, Kityo CM, Siwale M, et al
    Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multi-country longitudinal cohort analysis.
    AIDS. 2022 May 24. pii: 00002030-990000000-00021.
    PubMed     Abstract available

  562. YU X, Baillargeon J, Berenson AB, Westra JR, et al
    Incident depression among Medicare beneficiaries with disabilities and HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00020.
    PubMed     Abstract available

  563. VANPOUILLE C, Wells A, Wilkin T, Mathad JS, et al
    Sex differences in cytokine profiles during suppressive antiretroviral therapy.
    AIDS. 2022 May 24. pii: 00002030-990000000-00022.
    PubMed     Abstract available

  564. PORTWOOD C, Sexton H, Kumarendran M, Brandon Z, et al
    Adverse perinatal outcomes associated with HAART and monotherapy: systematic review and meta-analysis.
    AIDS. 2022 May 24. pii: 00002030-990000000-00018.
    PubMed     Abstract available

  565. LUO Q, Pfeiffer RM, Noone AM, Horner MJ, et al
    Years of life lost to cancer among the US HIV population, 2006-2015.
    AIDS. 2022 May 24. pii: 00002030-990000000-00024.
    PubMed     Abstract available

  566. SUAREZ-ZDUNEK MA, Hogh J, Kirkegaard-Klitbo DM, Jensen AMR, et al
    High incidence of subclinical peripheral artery disease in people with HIV.
    AIDS. 2022 May 24. pii: 00002030-990000000-00016.
    PubMed     Abstract available

  567. GIOVENCO D, Pettifor A, Powers KA, Hightow-Weidman L, et al
    Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women.
    AIDS. 2022 May 17. pii: 00002030-990000000-00015.
    PubMed     Abstract available

  568. SHEN Y, Shiau S, Yin MT, Arpadi SM, et al
    Cytokines in HIV infection: authors' reply.
    AIDS. 2022;36:908-909.

  569. MUNHOZ LGC, De Moraes-Pinto MI
    Cytokines in HIV infection: different methods of assessment require different interpretations.
    AIDS. 2022;36:907-908.

  570. CICHOWITZ C, Masoza T, Peck RN
    Air pollution and preclinical atherosclerotic cardiovascular disease in adolescents living with HIV: an opportunity for prevention.
    AIDS. 2022;36:901-902.

    Strategies to improve HIV care outcomes for people with HIV who are out of care: the need for well designed health systems.
    AIDS. 2022;36:899-900.

  572. NEL J, Gupta-Wright A
    Urine tuberculosis diagnostics in patients with advanced HIV.
    AIDS. 2022;36:897-898.

    April 2022
  573. TETENS MM, Gerstoft J, Kronborg G, Johansen IS, et al
    Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00014.
    PubMed     Abstract available

  574. AUNG HL, Gates TM, Mao L, Brew BJ, et al
    Abnormal cognitive aging in people with HIV: Evidence from Data Integration between two countries' cohort studies.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00013.
    PubMed     Abstract available

  575. KAZEMIAN P, Ding DD, Scott JA, Feser MK, et al
    The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.
    AIDS. 2022 Apr 26. pii: 00002030-990000000-00012.
    PubMed     Abstract available

  576. SAX PE, Andreatta K, Molina JM, Daar ES, et al
    High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with Suppressed HIV and Preexisting M184 V/I.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00011.
    PubMed     Abstract available

  577. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
    PubMed     Abstract available

  578. VOGT SL, Maloma L, Xian RR, Ambinder RF, et al
    Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
    PubMed     Abstract available

  579. WEINBERG A, Giganti MJ, Sirois PA, Montepiedra G, et al
    Coordination of inflammatory responses in children with perinatally-acquired HIV infection.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00008.
    PubMed     Abstract available

  580. LEVI LI, Sharma S, Schleiss MR, Furrer H, et al
    Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00007.
    PubMed     Abstract available

  581. PONTICIELLO M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, et al
    How informal healthcare providers improve uptake of HIV testing: qualitative results from a randomized controlled trial.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00006.
    PubMed     Abstract available

  582. MONTEJANO R, Marcelo C, Falces-Romero I, Del Valle LG, et al
    Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV.
    AIDS. 2022;36:751-753.

  583. GENER AR, Kottilil S
    Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications.
    AIDS. 2022;36:749-750.

  584. BERNARDINO JI, Srinivasa S
    Proprotein convertase subtilisin/kexin type 9 inhibitors: a turning point in HIV-associated dyslipidemia?
    AIDS. 2022;36:745-747.

  585. OLALLA-SIERRA J, Martin-Escalante MD, Garcia-Alegria J, Rubio-Rivas M, et al
    Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain.
    AIDS. 2022;36:683-690.
    PubMed     Abstract available

  586. FILIP I
    Getting to the heart of the matter: the need for tailored cardiovascular prevention strategies in patients with HIV.
    AIDS. 2022;36:N1-N3.

  587. JOSEPH J, Boeke CE, Makadzange EE, Sithole K, et al
    Near-point-of-care viral load testing during pregnancy and viremia at delivery.
    AIDS. 2022;36:711-719.
    PubMed     Abstract available

    March 2022
  588. MAZZITELLI M, Sasset L, Trunfio M, di Meco E, et al
    Use of self-prescribed medications and complementary medicines in a cohort of women with HIV.
    AIDS. 2022;36:617-619.

    HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors' reply.
    AIDS. 2022;36:616-617.

  590. HUANG J, Liao L, Wang Y, Liu Q, et al
    Antagonism between hydrogen bonding and secondary chemical bonding to calcium in viruses.
    AIDS. 2022;36:615-616.

  591. LEPIK KJ, Wang L, Harris M, Mclinden T, et al
    Evolving patterns of antiretroviral drug interactions in people living with HIV in British Columbia, Canada.
    AIDS. 2022 Mar 11. pii: 00002030-990000000-00005.
    PubMed     Abstract available

  592. LEFEBVRE M, Secher S, Bouchez S, Vandamme YM, et al
    Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00002.
    PubMed     Abstract available

  593. LE HINGRAT Q, Collin G, Bachelard A, Ghosn J, et al
    Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00001.
    PubMed     Abstract available

  594. RIAL-CRESTELO D, Otero B, Perez-Ayala A, Pinto A, et al
    Severe diarrhea by Cystoisospora belli in a well controlled HIV-infected patient.
    AIDS. 2022;36:485-486.

  595. SIM BZ, Smith LK, Yarwood T, Smith S, et al
    Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
    AIDS. 2022;36:483-485.

  596. XU X, Vesterbacka J, Aleman S, Nowak P, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:479-481.
    PubMed     Abstract available

    The persistent disparity in brain health among aging people with HIV.
    AIDS. 2022;36:475-477.

  598. POST JJ, Benfield T, Woolley I
    When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV.
    AIDS. 2022;36:473-474.

  599. STIRRUP O, Tostevin A, Ragonnet-Cronin M, Volz E, et al
    Diagnosis delays in the UK according to pre or postmigration acquisition of HIV.
    AIDS. 2022;36:415-422.
    PubMed     Abstract available

  600. ROUT SS, Di Y, Dittmer U, Sutter K, et al
    Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice.
    AIDS. 2022;36:325-336.
    PubMed     Abstract available

    February 2022
  601. PIMENTEL VF, Pingarilho M, Sole G, Alves D, et al
    Differential patterns of post-migration HIV-1 infection acquisition among Portuguese immigrants of different geographical origin.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96205.
    PubMed     Abstract available

  602. NANCE RM, Delaney JAC, Floyd JS, Saag MS, et al
    Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96204.
    PubMed     Abstract available

  603. DAUBY N, Gobert C, Benslimane A, Nagant C, et al
    Durability of tetanus seroprotection in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96211.
    PubMed     Abstract available

  604. DASGUPTA S, Crim SM, Dawson L, Kates J, et al
    Unmet needs for HIV ancillary care services by health care coverage and Ryan White HIV/AIDS program assistance.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96210.
    PubMed     Abstract available

  605. YAP SH, Lee CS, Furusho A, Ishii C, et al
    Plasma D-amino acids are associated with markers of immune activation and organ dysfunction in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96209.
    PubMed     Abstract available

  606. TORIAN LV, Forgione L, Wertheim JO
    Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985-2019.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96208.
    PubMed     Abstract available

  607. TUMKOSIT M, Han WM, Tankittiwat K, Chattranukulchai P, et al
    Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96207.
    PubMed     Abstract available

  608. ZANG X, Goedel WC, Bessey SE, Lurie MN, et al
    The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: A modeling study.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96206.
    PubMed     Abstract available

  609. HAMIDOUCHE M, Ante-Testard PA, Baggaley R, Temime L, et al
    Monitoring socioeconomic inequalities across HIV knowledge, attitudes, behaviours and prevention in 18 sub-Saharan African countries.
    AIDS. 2022 Feb 21. pii: 00002030-900000000-96212.
    PubMed     Abstract available

  610. DUGUE R, Schnall R, Liu M, Brickman AM, et al
    Uncontrolled HIV and inflammation is associated with intracranial saccular aneurysm presence: a preliminary study.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96214.
    PubMed     Abstract available

  611. FLETCHER CV, Kroon E, Schacker T, Pinyakorn S, et al
    Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96213.
    PubMed     Abstract available

  612. ALI MS, Wit MDE, Chabata ST, Magutshwa S, et al
    Estimation of HIV incidence from analysis of HIV prevalence patterns by age and years since starting sex work among female sex workers in Zimbabwe.
    AIDS. 2022 Feb 16. pii: 00002030-900000000-96216.
    PubMed     Abstract available

  613. HAWKINS C, Kang M, Bhattacharya D, Cloherty G, et al
    Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96218.
    PubMed     Abstract available

  614. WANJALLA CN, Temu TM, Mashayekhi M, Warren CM, et al
    IL-17A is associated with flow-mediated dilation and IL-4 with carotid plaque in persons with HIV.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96217.
    PubMed     Abstract available

  615. DAVIES C, Johnson L, Sawry S, Chimbetete C, et al
    Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96220.
    PubMed     Abstract available

  616. VINK FJ, Steenbergen RDM, Kremer WW, Lissenberg-Witte BI, et al
    Post-treatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96219.
    PubMed     Abstract available

  617. ZEGGAGH J, Bauer R, Delaugerre C, Carette D, et al
    Incidence and risk factors for recurrent sexually transmitted infections among men who have sex with men on HIV pre-exposure prophylaxis.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96224.
    PubMed     Abstract available

  618. GARCIA-OTERO L, Walles J, Balcha TT, Merga G, et al
    Cardiovascular effects of intrauterine exposure to maternal HIV and antiretroviral therapy in Ethiopian infants followed from fetal life.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96223.
    PubMed     Abstract available

  619. HUGUELEY B, Mcclung RP, Saduvala N, Oster AM, et al
    Baseline HIV drug resistance testing: 12 U.S. jurisdictions, 2014-2019.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96222.
    PubMed     Abstract available

  620. MANGURIAN C, Dahiya P, Goldman ML, Corbeil T, et al
    Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96221.
    PubMed     Abstract available

  621. TOE S, Nagy M, Albar Z, Yu J, et al
    Ambient air pollution is associated with vascular disease in ugandan HIV positive adolescents.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96226.
    PubMed     Abstract available

  622. JENNINGS L, Robbins RN, Nguyen N, Ferraris C, et al
    Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96225.
    PubMed     Abstract available

  623. DURIER C, Mercier-Delarue S, Verdiere NC, Meiffredy V, et al
    A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
    AIDS. 2022;36:319-321.

  624. VAN EMPEL E, De Vlieg RA, Harling G, Marcus ME, et al
    Reaching for the 'first 95': a cross-country analysis of HIV self-testing in nine countries in sub-Saharan Africa.
    AIDS. 2022;36:297-304.
    PubMed     Abstract available

  625. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy.
    AIDS. 2022;36:277-286.
    PubMed     Abstract available

  626. KUNIHOLM MH, Vasquez E, Appleton AA, Kingsley L, et al
    Cardiovascular risk score associations with frailty in men and women with or at risk for HIV.
    AIDS. 2022;36:237-347.
    PubMed     Abstract available

  627. DEL AMO J, Polo R, Moreno S, Jarrin I, et al
    SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
    AIDS. 2022;36:161-168.
    PubMed     Abstract available

  628. HERMANS LE, Hofstra LM, Schuurman R, Ter Heine R, et al
    HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment - week 96 results from the ITREMA trial.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96229.
    PubMed     Abstract available

  629. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
    Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
    PubMed     Abstract available

  630. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective cART.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96227.
    PubMed     Abstract available

  631. MURDOCH IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al
    Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?
    AIDS. 2022;36:322-323.

  632. GUANIRA JV, Fichtenbaum CJ
    Is it time to retire efavirenz as a first-line option worldwide?
    AIDS. 2022;36:317-318.

  633. JABS DA, Van Natta ML, Schneider MF, Pak JW, et al
    Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS.
    AIDS. 2022;36:177-184.
    PubMed     Abstract available

    January 2022
  634. WAKE RM, Govender NP, Omar SV, Ismail F, et al
    Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
    AIDS. 2022 Jan 24. pii: 00002030-900000000-96230.
    PubMed     Abstract available

  635. LI B, Zhang L, Liu Y, Xiao J, et al
    A novel prediction model to evaluate the probability of CD4/CD8 ratio restoration in HIV-infected individuals.
    AIDS. 2022 Jan 14. pii: 00002030-900000000-96239.
    PubMed     Abstract available

  636. HIGA DH, Crepaz N, Mullins MM, Adegbite-Johnson A, et al
    Strategies to improve HIV care outcomes for people with HIV who are out of care: a meta-analysis.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96232.
    PubMed     Abstract available

  637. BOCCARA F, Caramelli B, Calmy A, Kumar P, et al
    Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96231.
    PubMed     Abstract available

  638. JAKABEK D, Rae CD, Brew BJ, Cysique LA, et al
    Brain aging and cardiovascular factors in HIV: A longitudinal volume and shape MRI study.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96242.
    PubMed     Abstract available

  639. HASSOLD N, Brichler S, Ouedraogo E, Leclerc D, et al
    Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96241.
    PubMed     Abstract available

  640. DE LAZZARI E, Martinez-Mimbrero A, Chivite I, Gonzalez-Cordon A, et al
    Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96240.
    PubMed     Abstract available

  641. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96238.
    PubMed     Abstract available

  642. NOVAK RM, Armon C, Battalora L, Buchacz K, et al
    Aging, trends in CD4/CD8 ratio and clinical outcomes with persistent HIV suppression in the HIV outpatient study (HOPS).
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96237.
    PubMed     Abstract available

  643. CLARE M, Yang J, Lake JE, Abraham AG, et al
    Diabetes mellitus is associated with declines in physical function among men with and without HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96247.
    PubMed     Abstract available

  644. ALEDO MG, Canizares A, Vazquez-Rodriguez P, Castro A, et al
    Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96246.
    PubMed     Abstract available

  645. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
    Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
    PubMed     Abstract available

  646. CAMPBELL LM, Sun-Suslow N, Heaton A, Heaton RK, et al
    Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96244.
    PubMed     Abstract available

  647. JAROLIMOVA J, Platt LR, Curtis MR, Philpotts LL, et al
    Curable sexually transmitted infections among women with HIV in sub-Saharan Africa: systematic review and meta-analysis.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96243.
    PubMed     Abstract available

  648. ANDERSON AM, Bhondoekhan F, Curanovic D, Connelly MA, et al
    GlycA is associated with neuropsychological impairment in men with HIV.
    AIDS. 2022;36:156-159.

  649. ODENDAAL LN, Smit DP
    A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection.
    AIDS. 2022;36:155-156.

  650. CALZA L, Borderi M, Colangeli V, Miani T, et al
    Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2022;36:153-155.

  651. ZHU J, Wu X
    Save young lives by determining causes of children death stratified by HIV status in resource-constrained countries.
    AIDS. 2022;36:149-151.

  652. GENER AR
    Anticipating HIV drug resistance with appropriate sequencing methods.
    AIDS. 2022;36:147-148.

  653. YANAVICH C, Perazzo H, Li F, Tobin N, et al
    A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil.
    AIDS. 2022;36:49-58.
    PubMed     Abstract available

  654. AUGUSTE PE, Mistry H, McCarthy ND, Sutcliffe PA, et al
    Cost-effectiveness of testing for latent tuberculosis infection in people with HIV.
    AIDS. 2022;36:1-9.
    PubMed     Abstract available

    December 2021
  655. KNIGHTS SM, Lazarte SM, Kainthla R, Chiao EY, et al
    Mortality disparities among patients with HIV-associated kaposi's sarcoma in the southern united states.
    AIDS. 2021 Dec 22. pii: 00002030-900000000-96248.
    PubMed     Abstract available

  656. MCNEIL CJ, Lee JS, Cole SR, Patel SA, et al
    Anal cancer incidence in MSM with HIV: are black men at higher risk?
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96252.
    PubMed     Abstract available

  657. DRAK D, Shamu T, Heron JE, Chimbetete C, et al
    Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96251.
    PubMed     Abstract available

  658. CHAUSSADE H, Le-Marec F, Coureau G, Leleux O, et al
    Incidence of lung and HPV-associated malignancies in HIV-infected patients.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96250.
    PubMed     Abstract available

  659. KINGWARA L, Inzaule SC, Momanyi L, Jordan MR, et al
    Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor based regimens in children and adolescents in Kenya.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96249.
    PubMed     Abstract available

  660. SHAH S, Pilkington V, Hill A
    Is tenofovir disoproxil fumarate associated with weight loss?
    AIDS. 2021;35.
    PubMed     Abstract available

  661. VENTER WDF, Sokhela S, Calmy A, Mkhondwane L, et al
    Weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2021;35.
    PubMed     Abstract available

  662. JAMIESON L, Serenata C, Makhubele L, Sokhela S, et al
    Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial.
    AIDS. 2021;35.
    PubMed     Abstract available

  663. HARRIS EL, Blumer K, Perez Casas C, Ferris D, et al
    Accelerating access and scale-up of optimized antiretroviral therapy in low-income and middle-income countries: results of a coordinated end-to-end approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  664. PAPOT E, Kaplan R, Vitoria M, Polizzotto MN, et al
    Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective.
    AIDS. 2021;35.

  665. SINXADI PZ, Khoo SH, Boffito M
    Pharmacokinetic interactions of modern antiretroviral therapy.
    AIDS. 2021;35.
    PubMed     Abstract available

  666. CHANDIWANA NC, Serenata CM, Owen A, Rannard S, et al
    Impact of long-acting therapies on the global HIV epidemic.
    AIDS. 2021;35.
    PubMed     Abstract available

  667. MCCLUSKEY SM, Pepperrell T, Hill A, Venter WDF, et al
    Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era.
    AIDS. 2021;35.
    PubMed     Abstract available

  668. VENTER WDF, Serenata C, Vitoria M, Mkhondwane L, et al
    What we have learned from antiretroviral treatment optimization efforts over the last 5 years?
    AIDS. 2021;35.
    PubMed     Abstract available

  669. JANUS SE, Durieux JC, Hajjari J, Carneiro H, et al
    Inflammation mediated Vitamin K and Vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96253.
    PubMed     Abstract available

  670. LINTHWAITE B, Kronfli N, Marbaniang I, Ruppenthal L, et al
    Increased reengagement of out-of-care HIV patients using lost & found, a clinic-based intervention.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96254.
    PubMed     Abstract available

  671. RAWLINGS SA, Torres F, Wells A, Lisco A, et al
    Effect of HIV suppression on the cytokine network in blood and seminal plasma: A longitudinal study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96262.
    PubMed     Abstract available

  672. MONTEBATSI M, Lavoie MC, Blanco N, Marima R, et al
    Improving same-day ART in botswana: effects of a multifaceted national intervention.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96260.
    PubMed     Abstract available

  673. DALLA-POZZA P, Hentzien M, Allavena C, Maindreville AD, et al
    Progressive multifocal leukoencephalopathy in patients with immuno-virological control and at least 6 months of combination antiretroviral therapy.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96259.
    PubMed     Abstract available

  674. CARO-VEGAS C, Ramirez C, Landis J, Adimora AA, et al
    Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96258.
    PubMed     Abstract available

  675. SCHNEIDER JA, Hayford C, Hotton A, Tabidze I, et al
    Do partner services linked to molecular clusters yield people with viremia or new HIV? results from a historical cohort study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96257.
    PubMed     Abstract available

  676. GIROMETTI N, McCormack S, Tittle V, McOwan A, et al
    Rising rates of recent PrEP exposure among MSM newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96256.
    PubMed     Abstract available

  677. BEER L, Tie Y, Dasgupta S, McManus T, et al
    The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96255.
    PubMed     Abstract available

  678. LIANG HJ, Ernst T, Cunningham E, Chang L, et al
    Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96265.
    PubMed     Abstract available

  679. YU W, Jacobson DL, Williams PL, Patel K, et al
    Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96264.
    PubMed     Abstract available

  680. BAILIN SS, Kundu S, Wellons M, Freiberg MS, et al
    Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96263.
    PubMed     Abstract available

  681. NIKANJAM M, Tran L, Chadwick EG, Bwakura-Dangarembizi M, et al
    Impact of CYP2B6 genotype, TB therapy and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96261.
    PubMed     Abstract available

  682. LEE DH, Shin JE, Kim CH
    Sudden sensorineural hearing loss with vertigo as an initial presenting symptom of HIV/AIDS patient.
    AIDS. 2021;35:2553-2555.

  683. CATTANEO D, Fusi M, Micheli V, Resnati C, et al
    Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens.
    AIDS. 2021;35:2551-2553.

  684. SARKAR S, Bhondoekhan F, Haberlen S, Palella FJ Jr, et al
    The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV.
    AIDS. 2021;35:2549-2551.

  685. SPINELLI MA, Brown LB, Glidden DV, Hunter K, et al
    SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
    AIDS. 2021;35:2545-2547.
    PubMed     Abstract available

  686. MARAGH-BASS AC, Parker S, Thompson G, Erlandson KM, et al
    'Ending the HIV epidemic': where are African American women in the plan?
    AIDS. 2021;35:2541-2544.

  687. SLACK C, Soudeyns H
    Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries.
    AIDS. 2021;35:2539-2540.

  688. TUCKER JD, Iwelunmor J, Abrams E, Donenberg G, et al
    Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium.
    AIDS. 2021;35:2503-2511.
    PubMed     Abstract available

  689. RICHART V, Fernandez I, de Lazzari E, Berrocal L, et al
    High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption.
    AIDS. 2021;35:2463-2468.
    PubMed     Abstract available

  690. BOSWELL MT, Yindom LM, Hameiri-Bowen D, McHugh G, et al
    TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection.
    AIDS. 2021;35:2445-2450.
    PubMed     Abstract available

  691. LIU D, Liu J, Xu T, Qiao H, et al
    Longitudinal trajectories of brain volume in combined antiretroviral therapy treated and untreated simian immunodeficiency virus-infected rhesus macaques.
    AIDS. 2021;35:2433-2443.
    PubMed     Abstract available

    November 2021
  692. LAM JO, Lee C, Gilsanz P, Hou CE, et al
    Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
    AIDS. 2021 Nov 24. pii: 00002030-900000000-96266.
    PubMed     Abstract available

  693. Statin exposure and risk of cancer in people with and without HIV infection: Erratum.
    AIDS. 2021;35:2411.

  694. PRESSIAT C, Toni TD, Treluyer JM, Yonaba C, et al
    High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.
    AIDS. 2021;35:2409-2410.

  695. WANG P, McGovern M, Togo Y
    Geographic diversity in authorship of HIV randomized control trial publications.
    AIDS. 2021;35:2407-2409.

  696. BUKKEMS VE, Hidalgo-Tenorio C, Garcia C, van Hulzen AGW, et al
    First pharmacokinetic data of bictegravir in pregnant women living with HIV.
    AIDS. 2021;35:2405-2406.

  697. SNYMAN J, Sanders EJ, Ndung'u T
    COVID-19 in Africa: preexisting immunity and HIV.
    AIDS. 2021;35:2391-2393.

  698. DEAN LT, Chang HY, Goedel WC, Chan PA, et al
    Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA.
    AIDS. 2021;35:2375-2381.
    PubMed     Abstract available

  699. CARLANDER C, Lagheden C, Eklund C, Nordqvist Kleppe S, et al
    Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    AIDS. 2021;35:2367-2374.
    PubMed     Abstract available

  700. LUCAS GM, Winslow DL
    New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.
    AIDS. 2021;35:2395-2397.

  701. VANHAMEL J, Laga M
    Measuring progress in the roll-out of pre-exposure prophylaxis: from counting what we know, to knowing what to count.
    AIDS. 2021;35:2389-2390.

  702. TOULOUMI G, Thomadakis C, Pantazis N, Papastamopoulos V, et al
    HIV continuum of care: bridging cross-sectional and longitudinal analyses.
    AIDS. 2021 Nov 11. pii: 00002030-900000000-96268.
    PubMed     Abstract available

  703. DURSTENFELD MS, Sun K, Ma Y, Rodriguez F, et al
    Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96275.
    PubMed     Abstract available

  704. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    PubMed     Abstract available

  705. CACHAY ER, Hasteh F, Mathews WC
    Using computer-assisted content analysis to advance anal dysplasia natural history research: a validation study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96273.
    PubMed     Abstract available

  706. BIRABAHARAN M, Strunk A, Kaelber DC, Smith DM, et al
    Sex differences in type 2 diabetes mellitus prevalence among persons with HIV: a cross-sectional analysis.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96272.
    PubMed     Abstract available

  707. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed     Abstract available

  708. NEARY J, Langat A, Singa B, Kinuthia J, et al
    Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96270.
    PubMed     Abstract available

  709. ALTHOFF KN, Stewart CN, Humes E, Zhang J, et al
    The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96269.
    PubMed     Abstract available

  710. FOWLER MG, Aizire J, Sikorskii A, Atuhaire P, et al
    Growth deficits in antiretroviral and HIV exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months-of-age.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96277.
    PubMed     Abstract available

  711. MUNOZ-MORENO JA, Carrillo-Molina S, Martinez-Zalacain I, Miranda C, et al
    Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96276.
    PubMed     Abstract available

  712. YIN W, Panakadan S, Shwe YY, Peters K, et al
    Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific.
    AIDS. 2021;35:2229-2232.

  713. MOSES AK, Ghazi T, Naidoo DB, Chuturgoon A, et al
    DNA methylation of MEKKK1: a strategy to reactivate the NF-kappaB pathway and reverse HIV latency.
    AIDS. 2021;35:2221-2224.

  714. FORD N, Crawford KW, Ameyan W
    Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups.
    AIDS. 2021;35:2217-2219.

  715. NICHOLS BE, Rosen S
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
    AIDS. 2021;35:2235-2236.

  716. CLAASSEN CW, Lindsay B, Riedel DJ, Kafunda I, et al
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
    AIDS. 2021;35:2234-2235.

  717. HEIL EL, Pandit NS, Taylor GH
    Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
    AIDS. 2021;35:2232-2233.

  718. GENER AR
    Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
    AIDS. 2021;35:2215-2216.

  719. CACHAY ER, Hadigan C, Mathews WC
    Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
    AIDS. 2021;35:2211-2213.

  720. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS. 2021;35:2085-2094.
    PubMed     Abstract available

    October 2021
  721. MALMSTROM S, Wagner P, Yilmaz A, Svedhem V, et al
    Failure to restore CD4 count associated with infection-related and non-infection-related cancer.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96281.
    PubMed     Abstract available

  722. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96280.
    PubMed     Abstract available

  723. BECASEN JS, Morris JD, Denard CL, Mullins MM, et al
    HIV care outcomes among transgender persons with HIV infection in the united states: a systematic review and meta-analysis, 2006-2021.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96286.
    PubMed     Abstract available

  724. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
    The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
    PubMed     Abstract available

  725. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    PubMed     Abstract available

  726. CEDARBAUM ER, Ma Y, Adimora AA, Bamman M, et al
    Peripheral artery disease and physical function in women with and without HIV.
    AIDS. 2021 Oct 21. pii: 00002030-900000000-96285.
    PubMed     Abstract available

  727. RAMOS-RINCON JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, et al
    Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades.
    AIDS. 2021 Oct 20. pii: 00002030-900000000-96291.
    PubMed     Abstract available

  728. MILLS A, Richmond GJ, Newman C, Osiyemi O, et al
    Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.
    AIDS. 2021 Oct 13. pii: 00002030-900000000-96294.
    PubMed     Abstract available

  729. SIDDIQUI J, Samuel SK, Hayward B, Wirka KA, et al
    HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
    AIDS. 2021 Oct 12. pii: 00002030-900000000-96296.
    PubMed     Abstract available

  730. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
    AIDS. 2021 Oct 8. pii: 00002030-900000000-96295.
    PubMed     Abstract available

  731. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
    HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
    PubMed     Abstract available

  732. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed     Abstract available

  733. YAN H, Peters H, Thorne C
    Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96297.
    PubMed     Abstract available

  734. BEZEMER D, Blenkinsop A, Hall M, van Sighem A, et al
    In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission.
    AIDS. 2021 Oct 5. pii: 00002030-900000000-96312.
    PubMed     Abstract available

  735. SHAIKH K, Bhondoekhan F, Haberlen S, Nakanishi R, et al
    Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
    AIDS. 2021 Oct 4. pii: 00002030-900000000-96300.
    PubMed     Abstract available

    September 2021
  736. MOLDT B, Gunthard HF, Workowski KA, Little SJ, et al
    Evaluation of HIV-1 reservoir size and broadly neutralizing antibodies (bNAb) susceptibility in acute ART treated individuals.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96307.
    PubMed     Abstract available

  737. KYAW NTT, Kumar AMV, Harries AD, Satyanarayana S, et al
    Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96306.
    PubMed     Abstract available

  738. BREGER TL, Westreich D, Edmonds A, Edwards JK, et al
    A new smoking cessation "cascade" among women with or at risk for HIV infection.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96305.
    PubMed     Abstract available

  739. MCMAHON JH, Evans VA, Lau JSY, Symons J, et al
    Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96304.
    PubMed     Abstract available

  740. ONYANGO DO, Akelo V, van der Sande MAB, Ridzon R, et al
    Causes of death in HIV-infected and HIV-uninfected children in the child health and mortality prevention surveillance study-Kenya.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96303.
    PubMed     Abstract available

  741. KLINGLER J, Paul N, Laumond G, Schmidt S, et al
    Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96309.
    PubMed     Abstract available

  742. VIEIRA VA, Millar J, Adland E, Muenchhoff M, et al
    Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96308.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.